UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
	For the quarterly period ended	March 31, ~~2021~~2022


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
			For the transition period from __________________to __________________

1-13948

(Commission file number)

SCHWEITZER-MAUDUIT INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)


Delaware		62-1612879
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

100 North Point Center East,	Suite 600
Alpharetta,	Georgia	30022
(Address of principal executive offices)		(Zip Code)

1-800-514-0186

(Registrant’s telephone number, including area code)


Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol	Name of each exchange on which registered
Common stock, $0.10 par value	SWM	New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer," “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The Company had ~~31,409,529~~31,876,737 shares of common stock issued and outstanding as of May ~~5, 2021.~~4, 2022.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC.

TABLE OF CONTENTS


		Page
	Part I. - Financial Information
Item 1.	Financial Statements	1

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2726

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3635

Item 4.	Controls and Procedures	36
	Part II. - Other Information
Item 1.	Legal Proceedings	37

Item 1A.	Risk Factors	37

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3741

Item 3.	Defaults Upon Senior Securities	3741

Item 4.	Mine Safety Disclosures	3741

Item 5.	Other Information	3741

Item 6.	Exhibits	3842

Signatures		3943

Glossary of Terms		4044

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(dollars in millions, except per share amounts)

(Unaudited)


		Three Months Ended				Three Months Ended
		March 31, 2021		March 31, 2020				March 31, 2022		March 31, 2021
Net sales	Net sales	$	288.2	$	261.5		Net sales	$	406.8	$	288.2
Cost of products sold	Cost of products sold	207.4		187.2			Cost of products sold	314.2		207.4
Gross profit	Gross profit	80.8		74.3			Gross profit	92.6		80.8

Selling expense	Selling expense	9.1		9.5			Selling expense	14.3		9.1
Research and development expense	Research and development expense	3.8		3.2			Research and development expense	5.2		3.8
General expense	General expense	32.7		27.4			General expense	49.3		32.7
Total nonmanufacturing expenses	Total nonmanufacturing expenses	45.6		40.1			Total nonmanufacturing expenses	68.8		45.6

Restructuring and impairment expense	Restructuring and impairment expense	1.7		0.1			Restructuring and impairment expense	13.2		1.7
Operating profit	Operating profit	33.5		34.1			Operating profit	10.6		33.5
Interest expense	Interest expense	2.9		6.9			Interest expense	14.5		2.9
Other (expense) income, net		(2.6)		0.6
Other income (expense), net							Other income (expense), net	5.5		(2.6)
Income before income taxes and income from equity affiliates	Income before income taxes and income from equity affiliates	28.0		27.8			Income before income taxes and income from equity affiliates	1.6		28.0

Provision for income taxes	Provision for income taxes	7.4		5.3			Provision for income taxes	2.1		7.4
Income from equity affiliates, net of income taxes	Income from equity affiliates, net of income taxes	1.0		0			Income from equity affiliates, net of income taxes	2.1		1.0

Net income	Net income	$	21.6	$	22.5		Net income	$	1.6	$	21.6

Net income per share - basic:	Net income per share - basic:						Net income per share - basic:

Net income per share – basic	Net income per share – basic	$	0.69	$	0.72		Net income per share – basic	$	0.05	$	0.69

Net income per share – diluted:	Net income per share – diluted:						Net income per share – diluted:

Net income per share – diluted	Net income per share – diluted	$	0.68	$	0.72		Net income per share – diluted	$	0.05	$	0.68

Weighted average shares outstanding:	Weighted average shares outstanding:						Weighted average shares outstanding:

Basic	Basic	30,974,200		30,712,300			Basic	31,158,000		30,974,200

Diluted	Diluted	31,340,500		30,910,000			Diluted	31,413,700		31,340,500

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME ~~(LOSS)~~

(dollars in millions)

(Unaudited)

Three Months Ended
March 31, 2021 March 31, 2020
Net income $ 21.6 $ 22.5
Other comprehensive loss, net of tax:
Foreign currency translation adjustments (9.9) (3.5)
Unrealized gain (losses) on derivative instruments 4.4 (12.7)
Net gain from postretirement benefit plans 0.1 0.1
Less: amortization of postretirement benefit plans' costs included in net periodic cost 1.6 0.4
Other comprehensive loss (3.8) (15.7)
Comprehensive income $ 17.8 $ 6.8


	Three Months Ended
	March 31, 2022		March 31, 2021


Net income	$	1.6	$	21.6
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	8.7		(9.9)


Unrealized gains on derivative instruments	21.6		4.4
Less: Reclassification adjustment for gain on derivative instruments included in net income	1.1		—

Net loss from postretirement benefit plans	—		0.1
Amortization of postretirement benefit plans' costs included in net periodic cost	(0.7)		1.6
Other comprehensive income (loss)	30.7		(3.8)
Comprehensive income	$	32.3	$	17.8

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(dollars in millions, except per share amounts)

(Unaudited)


		March 31, 2021		December 31, 2020			March 31, 2022		December 31, 2021
ASSETS	ASSETS					ASSETS
Current assets	Current assets					Current assets
Cash and cash equivalents	Cash and cash equivalents	$	63.7	$	54.7	Cash and cash equivalents	$	56.1	$	74.7
Accounts receivable, net	Accounts receivable, net	172.9		148.5		Accounts receivable, net	278.5		238.0
Inventories	Inventories	173.3		179.7		Inventories	272.4		259.5
Income taxes receivable	Income taxes receivable	3.3		6.2		Income taxes receivable	3.7		10.0

Assets held for sale						Assets held for sale	6.7		—
Other current assets	Other current assets	14.9		7.3		Other current assets	20.6		12.4
Total current assets	Total current assets	428.1		396.4		Total current assets	638.0		594.6

Property, plant and equipment, net	Property, plant and equipment, net	324.1		339.0		Property, plant and equipment, net	450.4		463.9

Deferred income tax benefits	Deferred income tax benefits	0.2		2.6		Deferred income tax benefits	36.6		33.9
Investment in equity affiliates	Investment in equity affiliates	60.0		59.3		Investment in equity affiliates	66.8		64.6
Goodwill	Goodwill	401.8		403.7		Goodwill	646.8		648.3
Intangible assets	Intangible assets	304.8		314.7		Intangible assets	496.7		513.9
Other assets	Other assets	68.5		69.2		Other assets	106.6		101.1
Total assets	Total assets	$	1,587.5	$	1,584.9	Total assets	$	2,441.9	$	2,420.3

LIABILITIES AND STOCKHOLDERS’ EQUITY	LIABILITIES AND STOCKHOLDERS’ EQUITY					LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities	Current liabilities					Current liabilities
Current debt	Current debt	$	2.7	$	2.8	Current debt	$	2.9	$	3.2
Accounts payable	Accounts payable	66.6		60.5		Accounts payable	122.8		116.0
Income taxes payable	Income taxes payable	4.9		2.7		Income taxes payable	1.4		2.6

Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	83.5		100.9		Accrued expenses and other current liabilities	116.3		109.3
Total current liabilities	Total current liabilities	157.7		166.9		Total current liabilities	243.4		231.1

Long-term debt	Long-term debt	615.2		590.5		Long-term debt	1,273.5		1,267.1

Long-term income tax payable	Long-term income tax payable	17.7		17.7		Long-term income tax payable	16.6		16.6
Pension and other postretirement benefits	Pension and other postretirement benefits	35.3		36.5		Pension and other postretirement benefits	37.7		39.0
Deferred income tax liabilities	Deferred income tax liabilities	45.0		45.1		Deferred income tax liabilities	92.5		95.1
Other liabilities	Other liabilities	63.7		78.6		Other liabilities	76.8		89.2
Total liabilities	Total liabilities	934.6		935.3		Total liabilities	1,740.5		1,738.1
Stockholders’ equity:	Stockholders’ equity:					Stockholders’ equity:
Preferred stock, $0.10 par value; 10,000,000 shares authorized; NaN issued or outstanding		0		0
Common stock, $0.10 par value; 100,000,000 shares authorized; 31,407,136 and 31,324,745 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively		3.1		3.1
Preferred stock, $0.10 par value; 10,000,000 shares authorized; none issued or outstanding						Preferred stock, $0.10 par value; 10,000,000 shares authorized; none issued or outstanding	—		—
Common stock, $0.10 par value; 100,000,000 shares authorized; 31,705,664 and 31,449,563 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively						Common stock, $0.10 par value; 100,000,000 shares authorized; 31,705,664 and 31,449,563 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	3.1		3.1
Additional paid-in-capital	Additional paid-in-capital	94.6		92.2		Additional paid-in-capital	105.4		101.7
Retained earnings	Retained earnings	670.9		666.2		Retained earnings	681.2		696.4
Accumulated other comprehensive loss, net of tax	Accumulated other comprehensive loss, net of tax	(115.7)		(111.9)		Accumulated other comprehensive loss, net of tax	(88.3)		(119.0)
Total stockholders’ equity	Total stockholders’ equity	652.9		649.6		Total stockholders’ equity	701.4		682.2
Total liabilities and stockholders’ equity	Total liabilities and stockholders’ equity	$	1,587.5	$	1,584.9	Total liabilities and stockholders’ equity	$	2,441.9	$	2,420.3

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(dollars in millions, except per share amounts)

(Unaudited)


		Common Stock Issued												Common Stock Issued
		Shares	Amount		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total
Balance, December 31, 2019		30,896,661	$	3.1	$	78.8	$	638.4	$	(122.6)	$	597.7

Net income		—	—		—		22.5		—		22.5
Other comprehensive loss, net of tax		—	—		—		—		(15.7)		(15.7)
Dividends declared ($0.44 per share)		—	—		—		(13.7)		—		(13.7)
Restricted stock issuances, net		320,005	—		—		—		—		—
Stock-based employee compensation expense		—	—		2.1		—		—		2.1

Stock issued to directors as compensation		1,130	—		0.1		—		—		0.1
Purchases and retirement of common stock		(25,274)	—		—		(1.0)		—		(1.0)
Balance, March 31, 2020		31,192,522	$	3.1	$	81.0	$	646.2	$	(138.3)	$	592.0
														Shares	Amount		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive (Loss) Income		Total
Balance, December 31, 2020	Balance, December 31, 2020	31,324,745	$	3.1	$	92.2	$	666.2	$	(111.9)	$	649.6	Balance, December 31, 2020	31,324,745	$	3.1	$	92.2	$	666.2	$	(111.9)	$	649.6

Net income	Net income	—	—		—		21.6		—		21.6		Net income	—	—		—		21.6		—		21.6
Other comprehensive loss, net of tax	Other comprehensive loss, net of tax	—	—		—		—		(3.8)		(3.8)		Other comprehensive loss, net of tax	—	—		—		—		(3.8)		(3.8)
Dividends declared ($0.44 per share)	Dividends declared ($0.44 per share)	—	—		—		(13.8)		—		(13.8)		Dividends declared ($0.44 per share)	—	—		—		(13.8)		—		(13.8)
Restricted stock issuances, net	Restricted stock issuances, net	148,530	—		—		—		—		—		Restricted stock issuances, net	148,530	—		—		—		—		—
Stock-based employee compensation expense	Stock-based employee compensation expense	—	—		2.1		—		—		2.1		Stock-based employee compensation expense	—	—		2.1		—		—		2.1

Stock issued to directors as compensation													Stock issued to directors as compensation	590	—		0.3		—		—		0.3

Purchases and retirement of common stock													Purchases and retirement of common stock	(66,729)	—		—		(3.1)		—		(3.1)
Balance, March 31, 2021													Balance, March 31, 2021	31,407,136	$	3.1	$	94.6	$	670.9	$	(115.7)	$	652.9

Balance, December 31, 2021													Balance, December 31, 2021	31,449,563	$	3.1	$	101.7	$	696.4	$	(119.0)	$	682.2

Net income													Net income	—	—		—		1.6		—		1.6
Other comprehensive income, net of tax													Other comprehensive income, net of tax	—	—		—		—		30.7		30.7
Dividends declared ($0.44 per share)													Dividends declared ($0.44 per share)	—	—		—		(13.9)		—		(13.9)
Restricted stock issuances, net													Restricted stock issuances, net	350,154	—		—		—		—		—
Stock-based employee compensation expense													Stock-based employee compensation expense	—	—		3.4		—		—		3.4

Stock issued to directors as compensation	Stock issued to directors as compensation	590	—		0.3		—		—		0.3		Stock issued to directors as compensation	794	—		0.3		—		—		0.3
Purchases and retirement of common stock	Purchases and retirement of common stock	(66,729)	—		—		(3.1)		—		(3.1)		Purchases and retirement of common stock	(94,847)	—		—		(2.9)		—		(2.9)
Balance, March 31, 2021		31,407,136	$	3.1	$	94.6	$	670.9	$	(115.7)	$	652.9
Balance, March 31, 2022													Balance, March 31, 2022	31,705,664	$	3.1	$	105.4	$	681.2	$	(88.3)	$	701.4

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(dollars in millions)

(Unaudited)


		Three Months Ended					Three Months Ended
		March 31, 2021		March 31, 2020			March 31, 2022		March 31, 2021
Operating	Operating					Operating
Net income	Net income	$	21.6	$	22.5	Net income	$	1.6	$	21.6

Non-cash items included in net income:	Non-cash items included in net income:					Non-cash items included in net income:
Depreciation and amortization	Depreciation and amortization	16.9		15.3		Depreciation and amortization	25.1		16.9

Restructuring-related impairment						Restructuring-related impairment	12.9		—
Deferred income tax	Deferred income tax	3.0		0.7		Deferred income tax	(6.4)		3.0
Pension and other postretirement benefits	Pension and other postretirement benefits	1.1		0.8		Pension and other postretirement benefits	(1.9)		1.1
Stock-based compensation	Stock-based compensation	2.1		2.2		Stock-based compensation	3.4		2.1
Income from equity affiliates	Income from equity affiliates	(1.0)		0		Income from equity affiliates	(2.1)		(1.0)
Brazil tax assessment accruals, net	Brazil tax assessment accruals, net	(6.1)		0		Brazil tax assessment accruals, net	—		(6.1)

Other items	Other items	5.6		(2.7)		Other items	(5.8)		5.6
Cash received from settlement of interest swap agreements						Cash received from settlement of interest swap agreements	23.6		—
Changes in operating working capital, net of assets acquired:	Changes in operating working capital, net of assets acquired:					Changes in operating working capital, net of assets acquired:
Accounts receivable	Accounts receivable	(27.7)		(33.7)		Accounts receivable	(42.8)		(27.7)
Inventories	Inventories	1.8		10.8		Inventories	(16.8)		1.8
Prepaid expenses	Prepaid expenses	(4.8)		(3.5)		Prepaid expenses	(6.8)		(4.8)
Accounts payable		11.3		1.3
Accrued expenses and other current liabilities		(13.5)		(10.7)
Accounts payable and other current liabilities						Accounts payable and other current liabilities	16.1		(2.2)
Accrued income taxes	Accrued income taxes	2.4		2.1		Accrued income taxes	4.9		2.4
Net changes in operating working capital	Net changes in operating working capital	(30.5)		(33.7)		Net changes in operating working capital	(45.4)		(30.5)

Net cash provided by operations	Net cash provided by operations	12.7		5.1		Net cash provided by operations	5.0		12.7
Investing	Investing					Investing
Capital spending	Capital spending	(7.1)		(7.4)		Capital spending	(8.7)		(7.1)
Capitalized software costs	Capitalized software costs	(0.5)		(0.7)		Capitalized software costs	(0.9)		(0.5)
Acquisitions, net of cash acquired		0		(170.6)

Other investing	Other investing	0.3		2.4		Other investing	—		0.3
Net cash used in investing	Net cash used in investing	(7.3)		(176.3)		Net cash used in investing	(9.6)		(7.3)

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(dollars in millions)

(Unaudited)


		Three Months Ended					Three Months Ended
		March 31, 2021		March 31, 2020			March 31, 2022		March 31, 2021
Financing	Financing					Financing
Cash dividends paid to SWM stockholders	Cash dividends paid to SWM stockholders	(13.8)		(13.7)		Cash dividends paid to SWM stockholders	(13.9)		(13.8)

Proceeds from issuances of long-term debt	Proceeds from issuances of long-term debt	25.0		212.0		Proceeds from issuances of long-term debt	20.0		25.0
Payments on long-term debt	Payments on long-term debt	(0.6)		(0.4)		Payments on long-term debt	(14.4)		(0.6)
Payments on financing lease obligations						Payments on financing lease obligations	(0.2)		—
Purchases of common stock	Purchases of common stock	(3.1)		(1.0)		Purchases of common stock	(2.9)		(3.1)
Payments for debt issuance costs	Payments for debt issuance costs	(3.0)		0		Payments for debt issuance costs	(2.2)		(3.0)

Net cash provided by financing		4.5		196.9
Net cash (used in) provided by financing						Net cash (used in) provided by financing	(13.6)		4.5
Effect of exchange rate changes on cash and cash equivalents	Effect of exchange rate changes on cash and cash equivalents	(0.9)		(2.0)		Effect of exchange rate changes on cash and cash equivalents	(0.4)		(0.9)
Increase in cash and cash equivalents		9.0		23.7
(Decrease) increase in cash and cash equivalents						(Decrease) increase in cash and cash equivalents	(18.6)		9.0
Cash and cash equivalents at beginning of period	Cash and cash equivalents at beginning of period	54.7		103.0		Cash and cash equivalents at beginning of period	74.7		54.7
Cash and cash equivalents at end of period	Cash and cash equivalents at end of period	$	63.7	$	126.7	Cash and cash equivalents at end of period	$	56.1	$	63.7

Supplemental Cash Flow Disclosures	Supplemental Cash Flow Disclosures					Supplemental Cash Flow Disclosures
Cash paid for interest, net	Cash paid for interest, net	$	1.4	$	2.3	Cash paid for interest, net	$	7.6	$	1.4
Cash paid for taxes, net	Cash paid for taxes, net	$	2.0	$	2.3	Cash paid for taxes, net	$	3.4	$	2.0
Change in capital spending in accounts payable and accrued liabilities	Change in capital spending in accounts payable and accrued liabilities	$	4.9	$	2.9	Change in capital spending in accounts payable and accrued liabilities	$	5.3	$	4.9

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Note 1. General

Nature of Business

Schweitzer-Mauduit International, Inc. ("SWM," "we," or the "Company"), headquartered in the United States of America, is a ~~multinational diversified producer of~~leading global performance materials company, focused on bringing best-in-class innovation, design, and manufacturing solutions to our customers. Our highly engineered ~~solutions~~films, adhesive tapes, foams, nets, nonwovens, and ~~advanced materials~~papers are designed and manufactured using resins, polymers, and natural fibers for a variety of ~~industries.~~industries and specialty applications. The Company maintains 2 operating product line segments: Advanced Materials & Structures ("AMS") and Engineered ~~Papers.~~Papers ("EP").

The ~~Advanced Materials & Structures ("AMS")~~AMS segment ~~produces mostly~~offers design and manufacturing solutions for the healthcare, construction, industrial, transportation and filtration end-markets. We manufacture resin-based rolled goods such as nets, films and meltblown materials, ~~typically through an extrusion process or~~bonding products and adhesive components, along with providing adhesives and other ~~non-woven technologies. AMS also provides~~coating solutions and converting ~~and coating services. These products are used in a variety of specialty applications across the filtration, transportation, healthcare, construction, and industrial end-markets.~~services for our customers.

The ~~Engineered Papers ("EP")~~EP segment primarily serves the tobacco industry with production of various cigarette papers and reconstituted tobacco products ("Recon"). Traditional reconstituted tobacco leaf ("RTL") is used as a blend with virgin tobacco in cigarettes and used in the production of small cigars. Recon, as well as low ignition propensity ("LIP") cigarette paper, a specialty product with fire-safety features, are two key profit drivers, which together account for more than half of segment net sales. The EP segment also produces non-tobacco papers for premium applications, such as energy storage and industrial commodity paper grades.

We conduct business in over 90 countries and operate 2337 production locations worldwide, with offices and facilities in the U.S., Canada, United Kingdom, France, Luxembourg, Belgium, ~~Russia,~~ Brazil, China, Italy, Malaysia, India and Poland. We also have a 50% equity interest in 2 joint ventures in China. The first, China Tobacco Mauduit (Jiangmen) Paper Industry Ltd. ("CTM"), produces various cigarette papers and the second, China Tobacco Schweitzer (Yunnan) Reconstituted Tobacco Co. Ltd. ("CTS"), produces RTL.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements and the notes thereto have been prepared in accordance with the instructions of Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission ("SEC") and do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America ("U.S. GAAP"). However, such information reflects all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of results for the interim periods.

The results of operations for the three months ended March 31, ~~2021~~2022, are not necessarily indicative of the results to be expected for the full year. The unaudited condensed consolidated financial statements and these notes thereto included herein should be read in conjunction with the audited consolidated financial statements and the related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2020,~~2021, as filed with the SEC on March 1, ~~2021.~~2022.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned, majority-owned and controlled subsidiaries. The Company’s share of the net income of its 50%-owned joint ventures in China is included in the condensed consolidated statements of income as Income from equity affiliates, net of income taxes. Intercompany balances and transactions have been eliminated.

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and related disclosures of contingent assets and liabilities in the condensed consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, inventory valuation, useful lives of tangible and intangible assets, fair values, sales returns and rebates, receivables valuation, pension, postretirement and other benefits, restructuring and impairment, taxes and contingencies. Furthermore, the Company considered the ~~potential~~continuing impact from the global economic and social disruption caused by the novel coronavirus (“COVID-19”) in estimates used in the Company’s financial statements as of and for the period ended March 31, ~~2021.~~2022. The Company determined changes to these estimates did not have a material impact on our assessment of recoverability of our assets, including Accounts receivable, net, Goodwill, Intangible assets or long-lived assets. There may also be long-term undetermined effects on some of our customers and suppliers, and as a result of these uncertainties, actual results could differ materially from these estimates and assumptions.

~~Recently Adopted Accounting Standards~~

In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes." The new standard simplifies income tax accounting requirements by removing certain exceptions to the general principles in Topic 740, Income Taxes. The provisions of this ASU were adopted effective January 1, 2021 and did not have a material impact on the condensed consolidated financial statements.

In August 2018, the FASB issued ASU 2018-14, "Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20): Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans." The new standard modifies the annual disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans and requires the amendments to be applied on a retrospective basis for all periods presented. The provisions of this ASU were adopted effective January 1,2021 and the required changes, which are not significant and not expected to have a material impact, will be reflected in the annual financial statements.

Recently Issued Accounting Standards

In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The new standard provides optional expedients and exceptions for applying generally accepted accounting principles ("GAAP") to contracts, hedging relationships, and other transactions affected by reference rate reform and the anticipated discontinuance of the London Interbank Offered Rate ("LIBOR") if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020, through December 31, 2022. The Company does not currently have any contracts that have been changed to a new reference rate but will continue to evaluate the applicability and impact of the guidance.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 2. Revenue Recognition

The Company has 2 main sources of revenue: product sales and materials conversion. The Company recognizes product sales revenues when control of a product is transferred to the customer. For the majority of product sales, transfer of control occurs when the products are shipped from one of the Company’s manufacturing facilities to the customer. The cost of delivering finished goods to the Company’s customers is recorded as a component of Cost of products sold. Those costs include the amounts paid to a third party to deliver the finished goods. Any freight costs billed to and paid by a customer are included in net sales. The Company also provides services to customers through the conversion of customer-owned raw materials into processed finished goods. In these transactions, the Company generally recognizes revenue as processing is completed.

Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied, which generally occurs when control of the promised goods or services is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Generally, the Company considers collectability of amounts due under a contract to be probable upon inception of a sale based on an evaluation of the credit worthiness of each customer. If collectability is not considered to be probable, the Company defers recognition of revenue on satisfied performance obligations until the uncertainty is resolved. We record estimates for bad debts based on our expectations for the collectability of amounts due from customers, considering historical collection history, expectations for future activity and other discrete events as applicable.

Variable consideration, such as discounts or price concessions, is set forth in the terms of the contract at inception and is included in the assessment of the transaction price at the outset of the arrangement. The transaction price is allocated to the individual performance obligations due under the contract based on the relative stand-alone fair value of the performance obligations identified in the contract. The Company typically uses an observable price to determine the stand-alone selling price for separate performance obligations.

The Company does not typically include extended payment terms or significant financing components in its contracts with customers. Certain product sales contracts may include cash-based incentives (volume rebates or credits), which are accounted for as variable consideration. We estimate these amounts at least quarterly based on the expected forecast quantities to be provided to customers and reduce revenues recognized accordingly. Incidental items that are immaterial in the context of the contract are recognized as expense in the period incurred. The Company generally expenses sales commissions when incurred because the amortization period is one year or less. These costs are recorded within selling expenses. The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed. As a practical expedient, the Company treats shipping and handling activities that occur after control of the good transfers as fulfillment activities, and therefore, does not account for shipping and handling costs as a separate performance obligation.

~~Following is the Company’s Net sales disaggregated by revenue source ($ in millions). Sales and usage-based taxes are excluded from Net sales.~~

Three Months Ended
March 31, 2021 March 31, 2020
AMS EP Total AMS EP Total
Product revenues $ 158.3 $ 109.0 $ 267.3 $ 117.0 $ 124.7 $ 241.7
Materials conversion revenues 2.3 15.1 17.4 3.8 12.9 16.7
Other revenues 2.4 1.1 3.5 2.1 1.0 3.1
Total revenues (1)
$ 163.0 $ 125.2 $ 288.2 $ 122.9 $ 138.6 $ 261.5

~~(1) Revenues include net hedging gains and losses for the three months ended March 31, 2021 and 2020.~~

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Net sales are attributed to the following geographic locations based on the location of the Company’s direct customers ($ in millions):


		Three Months Ended													Three Months Ended
		March 31, 2021						March 31, 2020							March 31, 2022						March 31, 2021
		AMS		EP		Total		AMS		EP		Total			AMS		EP		Total		AMS		EP		Total
United States	United States	$	105.7	$	37.4	$	143.1	$	83.3	$	43.9	$	127.2	United States	$	152.0	$	38.6	$	190.6	$	105.7	$	37.4	$	143.1
Europe and the former Commonwealth of Independent States	Europe and the former Commonwealth of Independent States	17.8		49.4		67.2		12.6		43.5		56.1		Europe and the former Commonwealth of Independent States	64.1		51.0		115.1		17.8		49.4		67.2
Asia/Pacific (including China)	Asia/Pacific (including China)	32.4		22.2		54.6		20.7		28.8		49.5		Asia/Pacific (including China)	35.4		24.9		60.3		32.4		22.2		54.6
Latin America		2.4		8.8		11.2		2.3		11.0		13.3
Americas (excluding US)														Americas (excluding US)	14.2		12.7		26.9		2.4		8.8		11.2
Other foreign countries	Other foreign countries	4.7		7.4		12.1		4.0		11.4		15.4		Other foreign countries	7.2		6.7		13.9		4.7		7.4		12.1
Total revenues (1)	Total revenues (1)	$	163.0	$	125.2	$	288.2	$	122.9	$	138.6	$	261.5	Total revenues (1)	$	272.9	$	133.9	$	406.8	$	163.0	$	125.2	$	288.2

(1) Revenues include net hedging gains and losses for the three months ended March 31, ~~2021~~2022 and ~~2020.~~2021.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The AMS segment supplies customers serving generally high-growth end-markets, as follows.

Healthcare - Sales to the medical market include products used in woundcare, diagnostic test strips, consumer wellness, and hospital-setting products.

Construction - Sales to the construction end-market are comprised mostly of netting products for a range of erosion control and building applications.

Transportation - The Company’s primary products are aftermarket automotive paint protection films, in addition to ballistic resistant and security glass used in various transportation modes.

Filtration - The Company serves liquid and other filtration markets, producing reverse osmosis and other water filtration products along with media and support materials for air filtration devices.

Industrial - Sales to the industrial end-market include products for high-end coated digital printing, packaging, undersea cable wraps, consumer-oriented specialty tapes and wind-turbine production.

Net sales for the AMS business are disaggregated by end market as the percentage of the net sales as follows.


	Three Months Ended
	March 31, 2022		March 31, 2021
Healthcare	23	%	13	%
Construction	19	%	21	%
Industrial	24	%	15	%
Transportation	17	%	25	%
Filtration	17	%	26	%
Total revenues	100	%	100	%

Note 3. Other Comprehensive ~~Loss~~Income (Loss)

Comprehensive income (loss) includes Net income, as well as certain items charged and credited directly to stockholders' equity, which are excluded from net income. The Company has presented Comprehensive income in the condensed consolidated statements of comprehensive income (loss). Reclassification adjustments of derivative instruments are presented in Net sales, Other income (expense) ~~income,~~, net, or Interest expense in the condensed consolidated statements of income. See Note 11. Derivatives for additional information. Amortization of accumulated pension and other post-employment benefit ("OPEB") liabilities are included in the computation of net periodic pension and OPEB costs, which are more fully discussed in Note 13. Postretirement and Other Benefits.

Components of Accumulated other comprehensive loss, net of tax, were as follows ($ in millions):

March 31, 2021 December 31, 2020
Accumulated pension and OPEB liability adjustments, net of income tax benefit of $12.2 million and $11.6 million at March 31, 2021 and December 31, 2020, respectively $ (18.8) $ (20.5)
Accumulated unrealized loss on derivative instruments, net of income tax benefit of $2.8 million and $2.8 million at March 31, 2021 and December 31, 2020, respectively (8.7) (13.1)
Accumulated unrealized foreign currency translation adjustments, net of income tax benefit of $6.8 million and $10.1 million at March 31, 2021 and December 31, 2020, respectively (88.2) (78.3)
Accumulated other comprehensive loss $ (115.7) $ (111.9)

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	March 31, 2022		December 31, 2021


Accumulated pension and OPEB liability adjustments, net of income tax benefit of $6.9 million and $8.9 million at March 31, 2022 and December 31, 2021, respectively	$	(15.1)	$	(14.4)
Accumulated unrealized gain (loss) on derivative instruments, net of income tax benefit of $2.4 million and $2.1 million at March 31, 2022 and December 31, 2021, respectively	20.8		(1.9)
Accumulated unrealized foreign currency translation adjustments, net of income tax benefit of $12.1 million and $9.5 million at March 31, 2022 and December 31, 2021, respectively	(94.0)		(102.7)
Accumulated other comprehensive loss	$	(88.3)	$	(119.0)

Changes in the components of Accumulated other comprehensive (loss) income were as follows ($ in millions):

Three Months Ended
March 31, 2021 March 31, 2020
Pre-tax Tax Net of
Tax Pre-tax Tax Net of
Tax
Net gain (loss) on pension and OPEB liability adjustments $ 1.1 $ 0.6 $ 1.7 $ 0.7 $ (0.2) $ 0.5
Unrealized gain (loss) on derivative instruments 4.5 (0.1) 4.4 (15.6) 2.9 (12.7)
Unrealized (loss) gain on foreign currency translation (6.5) (3.4) (9.9) (4.1) 0.6 (3.5)
Total $ (0.9) $ (2.9) $ (3.8) $ (19.0) $ 3.3 $ (15.7)

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~




	Three Months Ended
	March 31, 2022						March 31, 2021
	Pre-tax		Tax		Net of Tax		Pre-tax		Tax		Net of Tax
Net gain (loss) on pension and OPEB liability adjustments	$	1.3	$	(2.0)	$	(0.7)	$	1.1	$	0.6	$	1.7
Unrealized gain (loss) on derivative instruments	22.4		0.3		22.7		4.5		(0.1)		4.4
Unrealized gain (loss) on foreign currency translation	6.1		2.6		8.7		(6.5)		(3.4)		(9.9)
Total	$	29.8	$	0.9	$	30.7	$	(0.9)	$	(2.9)	$	(3.8)

Note 4. Business Acquisitions

Neenah Merger

On March ~~13, 2020,~~28, 2022, SWM and Neenah Inc. ("Neenah") announced that the ~~Company~~parties entered into an agreement and plan of merger to combine, in an all-stock merger of equals (the “merger agreement”). Under the terms of the merger agreement, which was unanimously approved by the boards of directors of both companies, Neenah will merge with and into a merger subsidiary directly owned by SWM (the “merger”), with Neenah surviving the merger, such that following the merger, Neenah will become a direct, wholly-owned subsidiary of SWM. Pursuant to the merger agreement, stockholders of Neenah will receive 1.358 shares of SWM common stock for each share of Neenah common stock owned.The merger is expected to close in the second half of 2022, subject to receipt of requisite Neenah and SWM stockholder approval, receipt of requisite regulatory approvals and satisfaction of other customary closing conditions.Upon completion of the merger, Neenah will no longer be a separate publicly traded corporation. SWM will continue to trade on the New York Stock Exchange. See "Note 10—Debt" for further information about debt financing related to the merger.

Scapa

On April 15, 2021, SWM completed ~~the~~its previously announced acquisition of ~~100%~~Scapa Group plc (“Scapa”), a UK- based innovation, design, and manufacturing solutions provider for healthcare and industrial markets for aggregate cash consideration of $630.6 million, net of $22.7 million of Cash and cash equivalents acquired and including $568.9 million for the ~~equity interest in Tekra, LLC~~purchase of all Scapa ordinary shares, $75.9 million for the repayment of Scapa debt and ~~Trient, LLC, “Tekra,” pursuant~~$8.5 million for the repayment of acquisition costs incurred by Scapa. The acquisition adds to ~~the definitive agreement signed as~~SWM’s portfolio of ~~February 20, 2020. Tekra is a converter of high-performance films and substrates which enhances~~precision engineered performance materials, expands the Company’s ~~films capabilities. Tekra,~~innovation, design, and formulation capabilities, and brings a variety of new coating and converting technologies to SWM. Scapa, part of the AMS segment operates 2globally with manufacturing ~~facilities located~~and sales operations in ~~Wisconsin.~~the Americas, Asia and Europe.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

~~The consideration transferred to acquire Tekra was $169.3 million, net of $1.6 million cash and cash equivalents acquired, subject to working capital adjustments that were finalized in 2020.~~ The purchase price was funded with borrowings ~~from our Revolving~~under the amended Credit ~~Facility (as described under~~Agreement, as defined and discussed in Note 10. ~~Debt below).~~Debt.

The acquisition was accounted for as a business combination with the assets acquired and liabilities assumed measured at their fair values as of the acquisition date, primarily using Level 3 inputs.

The acquisition consideration allocation below is preliminary, pending completion of the fair value analyses of acquired assets and liabilities, including deferred taxes. The excess of the acquisition consideration over the estimated fair values of the acquired assets and assumed liabilities is assigned to goodwill. The goodwill which is assigned to the AMS reportable segment, is primarily attributable to expected revenue synergies and is not expected to be deductible for tax purposes. The estimated purchase price allocation disclosed as of ~~March 31, 2020,~~June 30, 2021 was revised during the ~~second and third quarters~~measurement period as new information was received and analyzed resulting in a decrease in ~~net intangible~~Deferred tax liabilities of $14.4 million, an increase in Property, plant and equipment of $7.7 million, an increase in Other liabilities, primarily due to changes in certain tax positions of $8 million, a $3.0 million decrease in Other assets, ~~of $3.4 million,~~ and other ~~adjustments, consisting primarily~~insignificant changes, as presented in the table below. As additional information related to income taxes becomes available, we may further revise the preliminary acquisition consideration allocation during the remainder of ~~reclassifications within working capital, leading to a net decrease in total consideration~~the measurement period, which will not exceed twelve months from the closing of ~~$1.8 million.~~the acquisition. Such revisions or changes may be material.

The consideration paid for ~~Tekra~~Scapa, and the ~~final~~preliminary estimated fair values of the assets acquired, and liabilities assumed as of the ~~March 13, 2020~~April 15, 2021, acquisition date ~~are~~were as follows ($ in millions):


	~~Fair Value as of March 13, 2020~~
~~Cash and cash equivalents~~	$	~~1.6~~
~~Accounts receivable~~	~~8.6~~
~~Inventory~~	~~14.2~~
~~Other current assets~~	~~0.2~~
~~Property, plant and equipment~~	~~7.3~~
~~Identifiable intangible assets~~	~~81.8~~
~~Other noncurrent assets~~	~~3.7~~
~~Total assets~~	$	~~117.4~~

~~Accounts payable~~	$	~~3.0~~
~~Other current liabilities~~	~~2.0~~
~~Other noncurrent liabilities~~	~~2.7~~

~~Net assets acquired~~	$	~~109.7~~

~~Goodwill~~	~~61.2~~

~~Total consideration~~	$	~~170.9~~


	Preliminary Fair Value as of March 31, 2022		Adjustments		Preliminary Fair Value as of April 15, 2021
Cash and cash equivalents	$	22.7	$	—	$	22.7
Accounts receivable	67.7		—		67.7
Inventory	60.0		(0.9)		60.9
Other current assets	9.7		(0.1)		9.8
Property, plant and equipment	159.8		7.7		152.1
Identifiable intangible assets	246.2		—		246.2
Other noncurrent assets	23.3		(3.0)		26.3
Total assets	$	589.4	$	3.7	$	585.7

Current debt	$	15.0	$	—	$	15.0
Accounts payable and other current liabilities	85.7		(0.2)		85.9
Deferred income tax liabilities	47.1		(14.4)		61.5
Other noncurrent liabilities	41.1		8.0		33.1
Net assets acquired	$	400.5	$	10.3	$	390.2
Goodwill	252.8		(10.3)		263.1
Total consideration	$	653.3	$	—	$	653.3

The fair value of receivables acquired approximates the gross contractual value.The contractual amount not expected to be collected is immaterial.

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Acquired inventory was comprised of finished goods and raw materials.The fair value of finished goods was based on net realizable value adjusted for the costs of selling and a reasonable profit margin on selling effort.The fair value of raw materials was determined to approximate book value.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Property, plant and equipment is comprised of buildings and leasehold improvements, machinery and equipment, furniture and fixtures, computer equipment, and construction in progress. The preliminary estimated fair value was determined using a reproduction/replacement cost approach which measures the value of an asset by estimating the cost to acquire or construct comparable assets adjusted for age and condition of the asset.

Acquired intangible assets include customer relationships, tradenames and ~~unpatented~~ developed technologies. Intangible assets were valued using the multi-period excess earnings and relief-from-royalty methods, both forms of the income approach which considers a forecast of future cash flows generated from the use of each asset.The following table shows the ~~final~~preliminary fair values assigned to identifiable intangible assets ($ in millions):

Fair Value as of March 13, 2020 Weighted-Average Amortization Period (Years)
Amortizable intangible assets:
Customer relationships $ 63.0 15
Tradenames and other 10.8 15
Developed technology 8.0 10
Total amortizable intangible assets $ 81.8


	Fair Value		Weighted-Average Amortization Period (Years)
Amortizable intangible assets:
Customer relationships	$	205.4	15
Tradenames and other	7.7		10
Developed technology	33.1		7
Total amortizable intangible assets	$	246.2

The preliminary estimate of deferred tax effects resulting from the acquisition include the expected federal, state, and foreign tax consequences associated with temporary differences between the preliminary fair values of the assets

acquired, liabilities assumed and the respective tax basis.

During the three months ended March 31, ~~2020,~~2022 and March 31, 2021 the Company recognized ~~$1.1 million in~~ direct and indirect acquisition-related costs for the ~~Tekra acquisition.~~Scapa acquisition of $0.0 million and $3.6 million, respectively. Direct and indirect acquisition-related costs were expensed as incurred and are included in the General expense line item in the condensed consolidated statements of income.

Pro Forma Financial Information

The ~~amounts~~supplemental pro forma financial information presents the combined results of ~~Net sales~~operations for the periods presented, as if the Scapa acquisition had occurred on January 1, 2020. The supplemental pro forma financial information includes the following adjustments related to the Scapa acquisition: amortization of intangible assets and ~~Net Income of Tekra included~~fair value adjustments to inventory, interest expense for the additional indebtedness incurred to complete the acquisition, transaction and severance costs, and applicable tax adjustments based on statutory rates in the ~~Company's condensed~~jurisdictions where the adjustments occurred. For the three months ended March 31, 2021, pro forma adjustments caused net income to increase by $10.3 million.

The supplemental pro forma financial information presented below is not necessarily indicative of consolidated ~~income statement from~~results of operations of the ~~acquisition date are~~combined business had the Scapa acquisitions occurred as ~~follows ($ in millions):~~of January 1, 2020.


	~~March 13, 2020 -~~ Three Months Ended
	March 31, ~~2020~~ 2021
Net ~~Sales~~sales	$	~~5.5~~409.8
Net ~~Income~~income	$	~~0.4~~31.9

The amount of unaudited pro forma Net sales for the three months ended March 31, 2020 for the combined entity were $285.4 million. Preparation of pro forma income from continuing operations for the periods presented is impractical given recent changes to the ownership structure of the acquired entities prior to the transaction.

Note 5. Net Income Per Share

The Company uses the two-class method to calculate earnings per share. The Company has granted restricted stock that contains non-forfeitable rights to dividends on unvested shares. Since these unvested shares are considered participating securities under the two-class method, the Company allocates earnings per share to common stock and participating securities according to dividends declared and participation rights in undistributed earnings.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Diluted net income per common share is computed based on Net income divided by the weighted average number of common and potential common shares outstanding. Potential common shares during the respective periods are those related to dilutive stock-based compensation, including long-term stock-based incentive compensation and directors’ accumulated deferred stock compensation, which may be received by the directors in the form of stock or cash. A reconciliation of the average number of common and potential common shares outstanding used in the calculations of basic and diluted net income per share follows ($ in millions, shares in thousands):

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~


		Three Months Ended				Three Months Ended
		March 31, 2021		March 31, 2020				March 31, 2022		March 31, 2021
Numerator (basic and diluted):	Numerator (basic and diluted):						Numerator (basic and diluted):
Net income	Net income	$	21.6	$	22.5		Net income	$	1.6	$	21.6
Less: Dividends paid to participating securities	Less: Dividends paid to participating securities	(0.1)		(0.3)			Less: Dividends paid to participating securities	(0.2)		(0.1)
Less: Undistributed earnings available to participating securities	Less: Undistributed earnings available to participating securities	(0.1)		0			Less: Undistributed earnings available to participating securities	—		(0.1)
Undistributed and distributed earnings available to common stockholders	Undistributed and distributed earnings available to common stockholders	$	21.4	$	22.2		Undistributed and distributed earnings available to common stockholders	$	1.4	$	21.4

Denominator:	Denominator:						Denominator:
Average number of common shares outstanding	Average number of common shares outstanding	30,974.2		30,712.3			Average number of common shares outstanding	31,158.0		30,974.2
Effect of dilutive stock-based compensation	Effect of dilutive stock-based compensation	366.3		197.7			Effect of dilutive stock-based compensation	255.7		366.3
Average number of common and potential common shares outstanding	Average number of common and potential common shares outstanding	31,340.5		30,910.0			Average number of common and potential common shares outstanding	31,413.7		31,340.5

Note 6. Inventories

Inventories are valued at the lower of cost (using the ~~First-In, First-Out~~first-in, first-out and weighted average methods) or net realizable value. The Company's costs included in inventory primarily include resins, pulp, chemicals, direct labor, utilities, maintenance, depreciation, finishing supplies and an allocation of certain overhead costs. Machine start-up costs or abnormal machine shutdowns are expensed in the period incurred and are not reflected in inventory. The Company reviews inventories at least quarterly to determine the necessity of write-offs for excess, obsolete or unsalable inventory. The Company estimates write-offs for inventory obsolescence and shrinkage. These reviews require the Company to assess customer and market demand. The following schedule details inventories by major class ($ in millions):


		March 31, 2021		December 31, 2020			March 31, 2022		December 31, 2021
Raw materials	Raw materials	$	65.2	$	65.3	Raw materials	$	119.5	$	113.4
Work in process	Work in process	24.6		23.2		Work in process	44.6		41.9
Finished goods	Finished goods	75.5		83.5		Finished goods	99.0		95.7
Supplies and other	Supplies and other	8.0		7.7		Supplies and other	9.3		8.5
Total	Total	$	173.3	$	179.7	Total	$	272.4	$	259.5

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 7. Goodwill

The changes in the carrying amount of goodwill by reportable segment for the three months ended March 31, ~~2021~~2022 were as follows ($ in millions):

AMS EP Total
Goodwill as of December 31, 2020 $ 398.4 $ 5.3 $ 403.7
Foreign currency translation adjustments (1.7) (0.2) (1.9)
Goodwill as of March 31, 2021 $ 396.7 $ 5.1 $ 401.8


	AMS		EP		Total
Goodwill as of December 31, 2021	$	643.4	$	4.9	$	648.3
Goodwill acquired during the period(1)	2.1		—		2.1
Foreign currency translation and other(2)	(3.5)		(0.1)		(3.6)
Goodwill as of March 31, 2022	$	642.0	$	4.8	$	646.8

(1) Related to measurement period adjustments for the Scapa acquisition.

(2) Goodwill with a carrying amount of $2.1 million was allocated to the disposal group classified as held for sale as of March 31, 2022 and subsequently impaired. Goodwill was allocated to the disposal group on the basis of relative fair value, primarily utilizing Level 3 inputs which included forecasted future cash flows. We considered the planned divestiture of this business as a potential indicator that the fair value of the AMS reporting unit may be below its carrying amount and performed a qualitative impairment assessment. As a result of this assessment, we concluded that as of March 31, 2022 the fair value of the reporting unit was in excess of its carrying value and therefore no impairment was identified or recognized.

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Note 8. Intangible Assets

The gross carrying amount and accumulated amortization for intangible assets which are in our AMS segment consisted of the following ($ in millions):


		March 31, 2021											March 31, 2022
		Gross Carrying Amount		Accumulated Amortization		Accumulated Impairments		Accumulated Foreign Exchange		Net Carrying Amount			Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Amortized Intangible Assets	Amortized Intangible Assets											Amortized Intangible Assets
Customer relationships	Customer relationships	$	339.2	$	94.1	$	0	$	(1.1)	$	246.2	Customer relationships	$	539.8	$	127.5	$	412.3
Developed technology(1)	Developed technology(1)	42.0		14.9		0		0.1		27.0		Developed technology(1)	72.0		20.7		51.3

Trade names	Trade names	32.7		1.6		20.7		0.3		10.1		Trade names	18.8		3.0		15.8
Non-compete agreements	Non-compete agreements	2.9		2.4		0		0		0.5		Non-compete agreements	2.9		2.6		0.3
Patents	Patents	1.5		0.6		0		0		0.9		Patents	1.9		0.6		1.3

Total	Total	$	418.3	$	113.6	$	20.7	$	(0.7)	$	284.7	Total	$	635.4	$	154.4	$	481.0

Unamortized Intangible Assets	Unamortized Intangible Assets											Unamortized Intangible Assets
Trade names		$	20.0	$	—	$	0.1	$	(0.2)	$	20.1
Trade names(1)												Trade names(1)	$	15.7	$	—	$	15.7

December 31, 2020
Gross
Carrying
Amount Accumulated
Amortization Accumulated Impairments Accumulated Foreign Exchange Net
Carrying
Amount
Amortized Intangible Assets
Customer relationships $ 339.8 $ 88.5 $ 0 $ (2.9) $ 254.2
Developed technology 42.1 14.1 0 (0.2) 28.2
Trade names 32.7 1.4 20.7 0.3 10.3
Non-compete agreements 2.9 2.4 0 0 0.5
Patents 1.5 0.5 0 0 1.0
Total $ 419.0 $ 106.9 $ 20.7 $ (2.8) $ 294.2
Unamortized Intangible Assets
Trade names $ 20.0 $ — $ 0.1 $ (0.6) $ 20.5
(1) Intangible assets with a net carrying amount of $4.7 million are included as part of the disposal group classified as held for sale at March 31, 2022.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	December 31, 2021
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Amortized Intangible Assets
Customer relationships	$	541.7	$	119.2	$	422.5
Developed technology	74.6		20.7		53.9

Trade names	18.9		2.7		16.2
Non-compete agreements	2.9		2.5		0.4
Patents	1.5		0.6		0.9
Total	$	639.6	$	145.7	$	493.9

Unamortized Intangible Assets
Trade names	$	20.0	$	—	$	20.0

Amortization expense of intangible assets was ~~$6.5~~$11.1 million and ~~$5.3~~$6.5 million for the three months ended March 31, ~~2021~~2022 and ~~2020,~~2021, respectively. Finite-lived intangibles in the AMS segment are expensed using the straight-line amortization method. The estimated average aggregate amortization expense is ~~$24.8~~$43.6 million in each of the next five years.

Note 9. Restructuring and Impairment Activities

The Company incurred restructuring and impairment ~~expense~~expenses of ~~$1.7~~$13.2 million, and ~~$0.1~~$1.7 million in the three months ended March 31, 2022 and 2021, ~~and 2020, respectively, in the EP segment.~~respectively.

~~During~~In the third quarter of 2020, we announced plans to shut down the Spotswood, New Jersey facility and shift the production of paper made there to other SWM facilities. This decision was part of our ongoing manufacturing optimization efforts and involved the co-development of a new paper production technology with one of the Company’s key customers. Production of paper at this facility ceased as of December 31, 2020.

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

~~As a result of this decision, $1.4 million of~~EP segment, restructuring and impairment ~~expense was recognized~~expenses were $0.3 million and $1.7 million in the three months ended March 31, 2022 and 2021, respectively. Restructuring and impairment expense for the three months ended March 31, 2022 includes $0.3 million related to pension benefits for the ~~costs associated with closing this~~Winkler, Manitoba facility, ~~maintaining the property~~which was closed in 2021. Restructuring and ~~preparing it for sale.~~

~~In addition to restructuring costs relating to the Spotswood facility, the EP segment recognized $0.3 million and $0.1 million~~impairment expense for the three months ended March 31, 2021 included

$1.4 million related to the Spotswood site, which was sold in 2021, and ~~2020, respectively,~~$0.3 million related to severance accruals ~~for employees~~ at other manufacturing ~~facilities. These restructuring charges relate to~~facilities as part of an ongoing cost optimization ~~initiatives to remain competitive within the EP segment.~~project. The ~~cost optimization initiative project started in 2019 and is expected to be completed in 2022.The EP segment has recognized $7.2 million~~Spotswood site was sold on December 9, 2021, for total proceeds of ~~restructuring charges cumulatively through March 31, 2021 related to this project.~~$34.4 million.

The Company expects to record additional restructuring and impairment and restructuring related costs in the EP segment during ~~2021~~2022 of approximately ~~$1.4~~$1.0 million relating to the ~~shutdown~~closing of the ~~Spotswood, New Jersey~~Winkler, Manitoba facility ~~primarily associated with closing~~for the ~~facility~~settlement of post-retirement benefit obligations and maintaining the property until it is sold. The Company does not expect to incur significant restructuring expenses related to the cost optimization initiatives in the EP segment during the remainder of 2021.retention.

In the AMS segment, ~~there~~restructuring and impairment expenses were 0$12.9 million for the three months ended March 31, 2022, primarily related to the write-down of certain assets in conjunction with the planned divestiture of a portion of the segment serving the construction end-market. After considering the impact of impairments, assets held for sale consist primarily of accounts receivable and inventories. There were no restructuring and impairment expenses for the three months ended March 31, ~~2021 and 2020.~~2021.

The following table summarizes total restructuring and related charges for the three months ended March 31, 2022 and 2021:

Three Months Ended
March 31, 2021 March 31, 2020
Restructuring and impairment expense:
Severance $ 0.3 $ 0.1
Other 1.4 0
Total restructuring and impairment expense $ 1.7 $ 0.1

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Three Months Ended
	March 31, 2022		March 31, 2021
Restructuring and impairment expense:
Severance	$	0.2	$	0.3
Other	0.1		1.4
Asset impairment	$	12.9	$	—
Total restructuring and impairment expense	$	13.2	$	1.7




Total other restructuring related charges - Cost of products sold	$	—	$	—

Total restructuring costs and related charges	$	13.2	$	1.7

The following table summarizes changes in restructuring liabilities during the periods ended March 31, ~~2021~~2022 and ~~December 31, 2020.~~2021. ($ in millions):


		Three Months Ended					Three Months Ended
		March 31, 2021		March 31, 2020			March 31, 2022		March 31, 2021
Balance at beginning of year	Balance at beginning of year	$	7.4	$	0.5	Balance at beginning of year	$	6.2	$	7.4
Accruals for announced programs	Accruals for announced programs	0.3		0.1		Accruals for announced programs	—		0.3
Cash payments	Cash payments	(2.2)		(0.3)		Cash payments	(1.4)		(2.2)
Foreign exchange impact	Foreign exchange impact	(0.1)		0		Foreign exchange impact	(0.1)		(0.1)
Balance at end of period	Balance at end of period	$	5.4	$	0.3	Balance at end of period	$	4.7	$	5.4

Restructuring liabilities were classified within Accrued expenses and other current liabilities and Other liabilities in each of the condensed consolidated balance sheets.

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Note 10. Debt

The components of total debt are summarized in the following table ($ in millions):


		March 31, 2021		December 31, 2020			March 31, 2022		December 31, 2021
Revolving credit facility - U.S. dollar borrowings	Revolving credit facility - U.S. dollar borrowings	$	75.0	$	50.0	Revolving credit facility - U.S. dollar borrowings	$	400.0	$	393.0

Term loan facility		195.0		195.5
Term loan A facility						Term loan A facility	193.0		193.5

6.875% senior unsecured notes due October 1, 2026, net of discount of $5.8 million and $6.1 million at March 31, 2021 and December 31, 2020, respectively		344.2		343.9
Term loan B facility						Term loan B facility	347.4		348.2
6.875% senior unsecured notes due October 1, 2026, net of discount of $4.9 million and $5.2 million at March 31, 2022 and December 31, 2021, respectively						6.875% senior unsecured notes due October 1, 2026, net of discount of $4.9 million and $5.2 million at March 31, 2022 and December 31, 2021, respectively	345.1		344.8
French employee profit sharing	French employee profit sharing	4.7		5.0		French employee profit sharing	4.0		4.1
Finance lease obligations	Finance lease obligations	3.3		3.5		Finance lease obligations	2.6		2.8

Debt issuance costs		(4.3)		(4.6)
Debt issuance costs and discounts						Debt issuance costs and discounts	(15.7)		(16.1)
Total debt	Total debt	617.9		593.3		Total debt	1,276.4		1,270.3
Less: Current debt	Less: Current debt	(2.7)		(2.8)		Less: Current debt	(2.9)		(3.2)
Long-term debt	Long-term debt	$	615.2	$	590.5	Long-term debt	$	1,273.5	$	1,267.1

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Credit Facility

On September 25, 2018, the Company entered into a $700.0 million credit agreement (the “Credit Agreement”), which replaced the Company’s previous senior secured credit facilities and provides for a five year $500.0 million revolving line of credit (the “Revolving Credit Facility”) and a seven year $200.0 million bank term loan facility (the “Term Loan A Facility”). Subject to certain conditions, including the absence of a default or event of default under the Credit Agreement, the Company may request incremental loans to be extended under the Revolving Credit Facility or as additional Term Loan Facilities so long as the Company is in pro forma compliance with the financial covenants set forth in the Credit Agreement and the aggregate of such increases does not exceed $400.0 million.

On February 10, 2021 we amended our Credit Agreement to, among other things, add a new seven year $350 million Term Loan B Facility (the “Term Loan B Facility”). and to decrease the incremental loans that may be extended at the Company’s request to $250 million. The Credit Agreement was further amended effective February 22, 2022 to adjust the step-down schedule for the maximum net debt to EBITDA ratio. The balance under the Term Loan B Facility was $0$347.4 million as of March 31, ~~2021.~~2022.

Borrowings under the Revolving Credit Facility currently bear interest, at the Company’s option, at either (i) ~~1.75%~~2.25% in excess of LIBOR or (ii) ~~0.75%~~1.25% in excess of an alternative base rate. Borrowings under the Term Loan A Facility currently bear interest, at the Company’s option, at either (i) ~~2.00%~~2.50% in excess of LIBOR or (ii) ~~1.00%~~1.50% in excess of an alternative base rate. The Term Loan amortizes at the rate of 1.0% per year and will mature on September 25, 2025. Any borrowings under the Term Loan B Facility will bear interest, at the Company's option, at either (i) ~~4.00%~~3.75% in excess of a reserve adjusted LIBOR rate (subject to a minimum floor of 0.75%) or (ii) ~~3.00%~~2.75% in excess of an alternative base rate.

Under the terms of the amended Credit Agreement, the Company is required to maintain certain financial ratios and comply with certain financial covenants, including maintaining a net debt to EBITDA ratio, as defined in the amended Credit Agreement, calculated on a trailing four fiscal quarter basis, not greater than ~~5.50~~5.50x and an interest coverage ratio, also as defined in the amended Credit Agreement, of not less than ~~3.00.~~3.00x. The net debt to EBITDA ratio will decrease over the course of 24 months, returning to 4.50x effective as of June 30, 2023. In addition, borrowings and loans made under the amended Credit Agreement are secured by substantially all of the Company’s and the guarantors’ personal property, excluding certain customary items of collateral, and will be guaranteed by the Company’s existing and future wholly-owned direct material domestic subsidiaries and by SWM Luxembourg.

The Company was in compliance with all of its covenants under the Credit Agreement at March 31, ~~2021.~~2022.

Debt Commitment Letter

In connection with the proposed merger with Neenah, SWM has obtained financing commitments for (i) a $648.0 million senior 364-day unsecured bridge facility (the “Bridge Facility”) and (ii) a $500.0 million senior secured revolving credit facility pursuant to a commitment letter (the “Debt Commitment Letter”) dated as of March 28, 2022.

The documentation governing the Bridge Facility and the Revolving Facility and actual financing terms have not been finalized, and accordingly, the actual terms may differ from the description of such terms in the Debt Commitment Letter.

Indenture for 6.875% Senior Unsecured Notes Due 2026

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

On September 25, 2018, the Company closed a private offering of $350.0 million of 6.875% senior unsecured notes due 2026 (the “Notes”). The Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended, pursuant to a purchase agreement between the Company, certain subsidiaries of the Company and J.P. Morgan Securities LLC, as representative of the initial purchasers. The Notes are guaranteed on a senior unsecured basis by each of the Company’s existing and future wholly-owned subsidiaries that is a borrower under or that guarantees obligations under the Credit Agreement or that guarantees certain other indebtedness, subject to certain exceptions.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The Notes were issued pursuant to an Indenture, dated as of September 25, 2018 (the “Indenture”), by and among the Company, the guarantors listed therein and Wilmington Trust, National Association, as trustee. The Indenture provides that interest on the Notes will accrue from September 25, 2018 and is payable semi-annually in arrears on April 1 and October 1 of each year, beginning on April 1, 2019, and the Notes mature on October 1, 2026.

The Company may redeem some or all of the Notes at any time on or after October 1, 2021, at the redemption prices set forth in the Indenture, together with accrued and unpaid interest, if any, to, but excluding, the redemption date. Prior to October 1, 2021, the Company may redeem some or all of the Notes at a price equal to 100% of the principal amount thereof, plus a “make-whole” premium as set forth in the Indenture. The Company may redeem up to 35% of the original aggregate principal amount of the Notes on or prior to October 1, 2021 with the proceeds of certain equity offerings at a redemption price equal to 106.875% of the principal amount of the Notes. If the Company sells certain assets or consummates certain change of control transactions, the Company will be required to make an offer to repurchase the Notes, subject to certain conditions.

The Indenture contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to incur additional indebtedness, make certain dividends, repurchase Company stock or make other distributions, make certain investments, create liens, transfer or sell assets, merge or consolidate and enter into transactions with the Company’s affiliates. Such covenants are subject to a number of exceptions and qualifications set forth in the Indenture. The Indenture also contains certain customary events of default, including failure to make payments in respect of the principal amount of the Notes, failure to make payments of interest on the Notes when due and payable, failure to comply with certain covenants and agreements and certain events of bankruptcy or insolvency. The Company was in compliance with all of its covenants under the Indenture at March 31, ~~2021.~~2022.

As of March 31, ~~2021,~~2022, the average interest rate was ~~2.33%~~3.10% on outstanding Revolving Credit Facility borrowings, ~~and 1.88%~~3.25% on outstanding Term Loan A Facility borrowings, and 4.50% on outstanding Term Loan B Facility borrowings. The effective rate on the 6.875% senior unsecured notes due 2026 was 7.248%. The weighted average effective interest rate on the Company's debt facilities, including the impact of interest rate hedges, was approximately ~~4.03%~~4.45% and ~~3.84%~~4.03% for the three months ended March 31, ~~2021~~2022 and ~~2020,~~2021, respectively.

As of March 31, ~~2021,~~2022, and December 31, ~~2020,~~2021, the Company's total deferred debt issuance costs and discounts, net of accumulated amortization, were ~~$4.3~~$15.7 million and ~~$4.6~~$16.1 million, respectively. Amortization expense of $0.3 million and $0.3 million was recorded during the three months ended March 31, 2021 and 2020, respectively, and has been included as a component of Interest expense in the accompanying condensed consolidated statements of income.

Principal Repayments

Following are the expected maturities for the Company's debt obligations as of March 31, ~~2021~~2022 ($ in millions):

2021 $ 3.4
2022 4.0
2023 78.4
2024 2.6
2025 188.7
Thereafter 345.1
Total $ 622.2

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~


2022	$	5.6
2023	406.7
2024	6.3
2025	192.5
2026	349.7
Thereafter	331.3
Total	$	1,292.1

Fair Value of Debt

At March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, the fair market value of the Company's 6.875% senior unsecured notes was ~~$373.1~~$330.8 million and ~~$371.0~~$365.8 million, respectively. The fair market value for the senior unsecured notes was determined using quoted market prices, which are directly observable Level 1 inputs. The fair market value of all other debt as of March 31, ~~2021~~2022 and December 31, ~~2020~~2021 approximated the respective carrying amounts as the interest rates are variable and based on current market indices.

~~Debt Issuance Costs~~

In conjunction with amendment to our Credit Agreement on February 10, 2021, the Company capitalized approximately $4 million of debt issuance costs during three months ended March 31, 2021 which will be amortized over the term of the various facilities under the amended Credit Agreement.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 11. Derivatives

In the normal course of business, the Company is exposed to foreign currency exchange rate risk and interest rate risk on its variable-rate debt. To manage these risks, the Company utilizes a variety of practices including, where considered appropriate, derivative instruments. The Company has no derivative instruments for trading or speculative purposes or derivatives with credit risk-related contingent features. All derivative instruments used by the Company are either exchange traded or are entered into with major financial institutions in order to reduce credit risk and risk of nonperformance by third parties. The fair values of the Company’s derivative instruments are determined using observable inputs and are considered Level 2 assets or liabilities.

The Company utilizes currency forward, swap and, to a lesser extent, option contracts to selectively hedge its exposure to foreign currency risk when it is practical and economical to do so. The use of these contracts minimizes transactional exposure to exchange rate changes. We designate certain of our foreign currency hedges as cash flow hedges. Changes in the fair value of cash flow hedges are reported as a component of Accumulated other comprehensive loss and reclassified into earnings when the forecasted transaction affects earnings. For foreign exchange contracts not designated as cash flow hedges, changes in the contracts’ fair values are recorded to net income each period.

The Company selectively hedges its exposure to interest rate increases on variable-rate, long-term debt when it is practical and economical to do so. Changes in the fair value of interest rate contracts considered cash flow hedges are reported as a component of Accumulated other comprehensive loss and reclassified into earnings when the forecasted transaction affects earnings.

The Company also uses cross currency swap contracts to selectively hedge its exposure to foreign currency related changes in our net investments in certain foreign operations. We designate these cross currency swap contracts as net investment hedges. Changes in the fair value of these hedges are deferred within the foreign currency translation component of Accumulated other comprehensive income and reclassified into earnings when the foreign investment is sold or substantially liquidated.

~~On September 11,~~During 2019 and 2021, the Company entered into a series of pay-fixed, receive-variable interest rate ~~swap with~~swaps, maturing on January 31, 2027 and December 31, 2027. During March of 2022, the interest rate swaps, which had a ~~maturity date~~combined notional value of $500 million were terminated and a total settlement of $23.6 million was received from the counterparties. The settlement amount, which represents the fair value of contracts at the time of termination, was recorded in Accumulated other comprehensive loss and will be amortized as a component of interest expense over the remaining term of the hedged forecasted transaction.

During March of 2022, immediately following the termination of the aforementioned interest rate swaps, the Company entered into pay-fixed, receive-variable interest rate swaps, maturing on January 31, 2027 and December 31, 2027. The ~~instrument is~~swaps have a ~~hedge on a portion~~combined notional value of $500 million which declines over the terms of the ~~Company’s debt facility through the Credit Agreement. Under the~~underlying contracts.

The terms of the interest rate swap, SWM will pay a fixed amount of interest each period in an amount equal to 1.724% on a notional amount of $185 million and receive interest payments monthly in an amount equal to the One-Month USD-LIBOR rate on the notional amount. The notional amount will reduce throughout the term of the swap as follows:

•~~September 13, 2019 - December 31, 2020 $185 million notional~~

•~~December 31, 2020 - December 31, 2021 $150 million notional~~

•~~December 31, 2021 - January 31, 2027 $100 million notional~~

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

~~As with the previous interest rate swap, the terms of the swap~~swaps mirror the terms of the underlying debt, including timing of the payments and interest rates.

~~On October 24, 2018, the~~The Company has also entered into a cross-currency ~~swap with a major financial institution~~swaps designated as a hedge of a portion of the ~~Company's~~Company’s net investment in ~~certain~~ Euro-denominated subsidiaries. ~~The~~These contracts involve the periodic exchange of U.S. dollar fixed interest rate payments in exchange for fixed Euro-denominated payments over the respective contract terms, ~~of the cross-currency swap provide for~~in addition to an exchange of ~~principal on a~~ notional ~~amount of $75 million swapped to €65.4 million at~~amounts upon maturity. The ~~Company will receive~~contracts, which extend from ~~our swap counterparty U.S. dollar interest at~~2023 to 2031 have a ~~fixed rate~~combined notional value of ~~6.875% per annum and pay to our swap counterparty Euro interest at a fixed rate of 3.6725% per annum. The cross-currency swap will mature on October 1, 2021.~~

On January 29, 2019, the Company entered into a cross-currency swap with a major financial institution designated as a hedge of a portion of the Company's net investment in certain Euro-denominated subsidiaries. The terms of the cross-currency swap provide for an exchange of principal on a notional amount of $75€488.8 million swapped to €66.0 million at maturity. The Company will receive from our swap counterparty U.S. dollar interest at a fixed rate of 6.875% per annum and pay to our swap counterparty Euro interest at a fixed rate of 4.0525% per annum. The cross-currency swap will mature on October 1, 2021.

On September 11, 2019, the Company entered into a new pay-EUR, receive-USD cross-currency swap arrangement with a major financial institution having a maturity date of April 1, 2023. The terms of the cross-currency swap provide for an exchange of principal on a notional amount of $100 million swapped to €90.9 million at maturity. Under the terms of the new cross-currency swap, SWM will pay a fixed amount of Euro-denominated interest at a rate of 5.638% semiannually and receive USD denominated payments at a rate of 6.875% semiannually on the notional amount of the swap.

~~On January 26, 2021, in anticipation of our announcement of our offer to acquire Scapa Group (as defined in and~~

further described under Note 16. Subsequent Events, below), we entered into a currency forward contract with a major financial institution. The terms of the contract provide for an exchange of a notional amount of GBP 439 million for USD, calculated using the contract rate as applicable at the settlement date. An additional currency forward contract with a major financial institution provides for the exchange of a notional amount of GBP 9.6 million for USD, calculated using the contract rate on April 21, 2021. See Note 16. Subsequent Events for additional information on the settlement of these contracts.($550 million).

The following table presents the fair value of asset and liability derivatives and the respective condensed consolidated balance sheet locations at March 31, ~~2021~~2022 ($ in millions):

Asset Derivatives Liability Derivatives
Balance Sheet
Location Fair
Value Balance Sheet
Location Fair
Value
Derivatives designated as hedges:
Foreign exchange contracts Accounts receivable, net $ 2.6 Accrued expenses and other current liabilities $ 4.9
Foreign exchange contracts Other assets 0 Other liabilities 7.3
Interest rate contracts Accounts receivable, net 0 Other liabilities 3.6
Total derivatives designated as hedges 2.6 15.8
Derivatives not designated as hedges:
Foreign exchange contracts Accounts receivable, net 0 Accrued expenses and other current liabilities 5.7
Total derivatives not designated as hedges 0 5.7
Total derivatives $ 2.6 $ 21.5

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedges:
Foreign exchange contracts	Accounts receivable, net	$	4.1	Accrued expenses and other current liabilities	$	—
Foreign exchange contracts	Other assets	7.4		Other liabilities	2.2
Interest rate contracts	Accounts receivable, net	0.2		Other liabilities	0.5
Interest rate contracts	Other assets	0.7
Total derivatives designated as hedges		12.4			2.7

Derivatives not designated as hedges:
Foreign exchange contracts	Accounts receivable, net	—		Accrued expenses and other current liabilities	3.3
Total derivatives not designated as hedges		—			3.3
Total derivatives		$	12.4		$	6.0

The following table presents the fair value of asset and liability derivatives and the respective condensed consolidated balance sheet locations at December 31, ~~2020~~2021 ($ in millions):

Asset Derivatives Liability Derivatives
Balance Sheet
Location Fair
Value Balance Sheet
Location Fair
Value
Derivatives designated as hedges:
Foreign exchange contracts Accounts receivable, net $ 0.9 Accrued expenses $ 11.0
Foreign exchange contracts Other assets 0 Other liabilities 12.3
Interest rate contracts Accounts receivable, net 0.3 Accrued expenses 0
Interest rate contracts Other assets 0 Other liabilities 7.8
Total derivatives designated as hedges $ 1.2 $ 31.1
Derivatives not designated as hedges:
Foreign exchange contracts Accounts receivable, net 0 Accounts payable 0
Total derivatives not designated as hedges $ 0 $ 0
Total derivatives $ 1.2 $ 31.1


	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedges:
Foreign exchange contracts	Accounts receivable, net	$	1.6	Accrued expenses	$	—
Foreign exchange contracts	Other assets	—		Other liabilities	9.8
Interest rate contracts	Accounts receivable, net	0.2		Accrued expenses	—
Interest rate contracts	Other assets	3.3		Other liabilities	2.1
Total derivatives designated as hedges		$	5.1		$	11.9

Derivatives not designated as hedges:
Foreign exchange contracts	Accounts receivable, net	0.2		Accounts payable	0.6
Total derivatives not designated as hedges		$	0.2		$	0.6
Total derivatives		$	5.3		$	12.5

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table provides the ~~gross~~net effect that derivative instruments designated in hedging relationships had on Accumulated other comprehensive loss and results of operations ($ in millions):

Derivatives Designated in Hedging Relationships Unrealized (Loss) Gain Recognized in AOCI on Derivatives, Net of Tax Location of (Loss) Gain Reclassified
from AOCI (Loss) Gain Reclassified
from AOCI
Three Months Ended Three Months Ended
March 31, March 31,
2021 2020 2021 2020
Derivatives designated as cash flow hedge
Foreign exchange contracts $ (0.6) $ (5.0) Net sales $ (0.6) $ (0.6)
Foreign exchange contracts 0.9 0.5 Other income (expense), net 0.7 0.6
Interest rate contracts 4.1 (8.2) Interest expense 0 0
Derivatives designated as net investment hedge
Foreign exchange contracts 7.0 12.0 Other income (expense), net 0 0
Total $ 11.4 $ (0.7) $ 0.1 $ 0


Derivatives Designated in Hedging Relationships	Unrealized Gain (Loss) Recognized in AOCI on Derivatives, Net of Tax				Location of (Loss) Gain Reclassified from AOCI	(Loss) Gain Reclassified from AOCI

	Three Months Ended						Three Months Ended
	March 31,						March 31,
	2022		2021					2022		2021
Derivatives designated as cash flow hedge
Foreign exchange contracts	$	—	$	(0.6)			Net sales	$	—	$	(0.6)
Foreign exchange contracts	(0.1)		0.9				Other (expense) income, net	(0.1)		0.7
Interest rate contracts	21.7		4.1				Interest expense	(1.0)		—
Derivatives designated as net investment hedge
Foreign exchange contracts	13.6		7.0
Total gain (loss)	$	35.2	$	11.4				$	(1.1)	$	0.1

The Company's designated derivative instruments are highly effective. As such, related to the hedge ineffectiveness or amounts excluded from hedge effectiveness testing, there were no gains or losses recognized immediately in income for the three ~~and three~~ months ended March 31, ~~2021~~2022 or ~~2020,~~2021, other than those related to the cross-currency swap, noted below.

The Company’s cross currency swaps were designated with terms based on the spot rate of the EUR. Future changes in the components related to the spot change on the notional will be recorded in OCI and remain there until the hedged subsidiaries are substantially liquidated. All coupon payments are recorded in earnings and the initial value of excluded components currently recorded in Accumulated other comprehensive loss as an unrealized translation adjustment are amortized to interest expense over the remaining term of the swap. For the three months ended March 31, 2022 and 2021, ~~and 2020,~~ respectively, ~~$1.1~~$2.6 million and ~~$2.0~~$1.1 million was recognized in income as derivative amounts excluded from effectiveness testing as Interest expense.

The following table provides the effect that derivative instruments not designated as cash flow hedging instruments had on net income ($ in millions):

Derivatives Not Designated as Cash Flow Hedging Instruments

Location of Gain Recognized in Income

Amount of (Loss) Gain Recognized in Income

Derivatives Not Designated as Cash Flow Hedging Instruments

Location of Gain Recognized in Income

Amount of Gain (Loss) Recognized in Income

Three Months Ended

March 31, 2021

March 31, 2020

March 31, 2022

March 31, 2021

Foreign exchange contracts

Other income, net

(6.6)

0.2

Foreign exchange contracts

Other income (expense), net

(1.1)

(6.6)

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

~~Note~~ 12. Commitments and Contingencies

Litigation

Brazil

~~Imposto sobre Circulação de Mercadorias e Serviços ("ICMS"), a form of value-added tax in Brazil, was assessed to SWM-B in December of 2000. SWM-B~~SWM-Brazil "SWM-B" received 2 assessments from the tax authorities of the State of Rio de Janeiro (the "State") for unpaid ~~ICMS taxes on certain raw materials from January 1995 through October 1998 and from November 1998 through November 2000 (collectively, the "Raw Materials Assessments"~~Imposto sobre Circulação de Mercadorias e Serviços ("ICMS"). The Raw Materials Assessments concerned the accrual and use by SWM-B of ICMS tax credits generated from the production and sale of certain non-tobacco related grades of paper sold domestically. SWM-B contested the Raw Materials Assessments based on Article 150, VI of the Brazilian Federal Constitution of 1988, which grants immunity from ICMS taxes to papers intended for printing books, newspapers and periodicals, on the ground that tax immunity extends to the raw material inputs used to produce such papers. In 2015, the first chamber of the Federal Supreme Court decided the first Raw Materials Assessment in favor of SWM-B. Different chambers of the Federal Supreme Court decided one Raw Materials Assessment in favor of SWM-B and the other against SWM-B. SWM-B recorded a liability of $8.6 million (based on the foreign currency exchange rate at March 31, 2021) in Other Liabilities to satisfy the adverse judgment in the second quarter of 2019 and continued to pursue appeals. On April 9, 2021, SWM-B resolved the remaining Raw Materials Assessment by paying $2.6 million (based on the foreign currency exchange rate at March 31, 2021) under a tax amnesty program which reduced the tax liability by approximately 70%. All litigation is now concluded and this matter is fully resolved. As the result of the favorable settlement, we recognized a total benefit of $6.1 million in the first quarter of 2021, of which $4.6 million was in Interest expense and $1.6 million was in Other expense, net.

~~SWM-B received assessments from the tax authorities of the State for unpaid ICMS~~ and Fundo Estadual de Combate à Pobreza ("~~FECP," a~~FECP") value-added ~~tax similar to ICMS)~~ taxes on interstate purchases of electricity. The State issued 4 sets of assessments against SWM-B ~~one~~ for periods from May 2006 - November 2007, a second for January 2008 - December 2010, a third for September 2011 - September 2013, which was replaced by a smaller assessment for January - June 2013, and a fourth for July 2013 -through December 2017 (collectively the "Electricity Assessments"). SWM-B challenged all Electricity Assessments in administrative proceedings before the State tax council (in the ~~first-level court~~ Junta de Revisão Fiscal “first-level administrative court” and the ~~appellate court~~ Conselho de ~~Contribuintes)~~Contribuintes “administrative appellate court”) based on Resolution 1.610/89, which defers these taxes on electricity purchased by an "electricity-intensive consumer." In 2014, a majority of the ~~Conselho de Contribuintes~~administrative appellate court sitting en banc ruled against SWM-B in each of the first and second Electricity Assessments ($~~3.3~~11.9 million ~~and $6.3 million, respectively,~~ based on the foreign currency exchange rate at March 31, ~~2021)~~2022), and SWM-B is now pursuing challenges to these assessments in the State judicial system where SWM-B obtained preliminary injunctions against enforcement of both assessments. In March 2020, the first-level judicial court ruled in favor of SWM-B in the second Electricity Assessment, a decision that is now on appeal. The third Electricity Assessment was dismissed on technical grounds ~~by the Conselho de Contribuintes~~ in ~~2018 after the State admitted the tax did not apply as it had asserted. Instead, in~~2018. In August 2018, the State filed a revised third and fourth Electricity ~~Assessment in the~~Assessments for a combined amount of $0.5 million for ICMS on electricity purchased during part of 2013, and a fourth Electricity Assessment in the amount of $7.0 million pertaining to ICMS and FECP on electricity purchased from July 2013 to December 2017.$9.5 million. SWM-B filed challenges to these 2018 assessments in the first-level administrative court on the same grounds as the older ~~cases. The Junta de Revisão Fiscal rejected SWM-B’s challenge to~~cases, receiving unfavorable rulings from the revised third Electricity Assessment, but the Conselho de Contribuintes agreed with SWM-B that the 2013 claim was time-barred. Both the Junta de Revisão Fiscal and the Conselho de Contribuintes ruled against SWM-Bcourts in ~~the fourth Electricity Assessment.~~2019. Both 2019 decisions ~~from the Conselho de Contribuintes~~ are being ~~appealed to the full bench of the Conselho de Contribuintes.~~appealed. The State issued a new regulation effective January 1, 2018 that only specific industries are “electricity-intensive consumers,” a list that excludes paper manufacturers. SWM-B contends this regulation shows that paper manufacturers were electricity-intensive consumers eligible to defer ICMS before 2018.

SWM-B cannot determine the outcome of the Electricity Assessments matters; as such, 0no loss has been accrued in our condensed consolidated financial statements.

~~Germany~~

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

In December of 2000, SWM-B received 2 assessments from the tax authorities of the State for unpaid ICMS taxes on certain raw materials from January 1995 through October 1998 and from November 1998 through November 2000 (collectively, the "Raw Materials Assessments"). The Raw Materials Assessments concerned the accrual and use by SWM-B of ICMS tax credits generated from the production and sale of certain non-tobacco related grades of paper sold domestically. An adverse judgement was received during 2019 and a provision of $8.6 million (based on the foreign currency exchange rate at March 31, 2021) was recorded in Other Liabilities. On April 9, 2021, SWM-B resolved the Raw Materials Assessment by paying $2.6 million (based on the foreign currency exchange rate at March 31, 2021) under a tax amnesty program which reduced the tax liability by approximately 70%. All litigation is now concluded on this matter which is fully resolved. As the result of the favorable settlement, we recognized a total benefit of $6.1 million in the first quarter of 2021, of which $4.6 million was in Interest expense and $1.6 million was in Other expense, net.

Germany

In January 2015, the Company initiated patent infringement proceedings in Germany against Glatz under multiple LIP-related patents. In December, 2017, the Dusseldorf Appeal Court affirmed the German District Court judgment on infringement of EP1482815 against Glatz. The Company filed an action against Glatz in the German District Court to set the amount of damages for the infringement and Glatz has filed a counterclaim. Glatz ~~has~~ filed an action in the German Patent Court to invalidate the German part of EP1482815. The German Patent Court held that some of the patent claims at issue were invalid and also that another claim at issue was valid.The Company has appealed the portion of the decision with respect to the claims held to be invalid. The ~~hearing on this invalidity appeal~~German Supreme Court held that the claims of German counterpart of EP1482815 relevant to the Glatz infringement action were invalid. This ruling has ~~been~~the effect of nullifying the infringement decision and injunction against Glatz and the Company’s claim for damages against Glatz. Glatz’s counterclaim against the Company is still pending and is scheduled for ~~September 2021.~~hearing in February, 2023. The cost, timing and outcome of intellectual property litigation can be unpredictable and thus no assurances can be given as to the outcome or impact on us of such litigation.

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Environmental Matters

The Company's operations are subject to various nations' federal, state and local laws, regulations and ordinances relating to environmental matters. The nature of the Company's operations exposes it to the risk of claims with respect to various environmental matters, and there can be no assurance that material costs or liabilities will not be incurred in connection with such claims. While the Company has incurred in the past several years, and will continue to incur, capital and operating expenditures in order to comply with environmental laws and regulations, it believes that its future cost of compliance with environmental laws, regulations and ordinances, and its exposure to liability for environmental claims and its obligation to participate in the remediation and monitoring of certain hazardous waste disposal sites, will not have a material effect on its financial condition or results of operations. However, future events, such as changes in existing laws and regulations, or unknown contamination or costs of remediation of sites owned, operated or used for waste disposal by the Company (including contamination caused by prior owners and operators of such sites or other waste generators) may give rise to additional costs which could have a material effect on its financial condition or results of operations.

General Matters

In the ordinary course of conducting business activities, the Company and its subsidiaries become involved in certain other judicial, administrative and regulatory proceedings involving both private parties and governmental authorities. These proceedings include insured and uninsured regulatory, employment, intellectual property, general and commercial liability, environmental and other matters. At this time, the Company does not expect any of these proceedings to have a material effect on its reputation, business, financial condition, results of operations or cash flows. However, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, financial condition, results of operations or cash flows.

Note 13. Postretirement and Other Benefits

The Company sponsors pension benefits in the United States, France, United Kingdom, Italy, and Canada and OPEB benefits related to postretirement healthcare and life insurance in the United States and Canada. The Company’s Canadian ~~pension~~ and ~~OPEB~~Italian pension benefits and U.S. and Canadian OPEB liability are not material and therefore are not included in the following disclosures.

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Pension and OPEB Benefits

The components of net pension benefit costs for U.S., French and ~~French~~UK employees during the three months ended March 31, ~~2021~~2022 and ~~2020~~2021 were as follows ($ in millions):


		Three Months Ended March 31,								Three Months Ended March 31,
		U.S. Pension Benefits				French Pension Benefits					U.S. Pension Benefits				French Pension Benefits				UK Pension Benefits
		2021		2020		2021		2020					2022		2021		2022		2021		2022		2021
Service cost	Service cost	$	0	$	0	$	0.3	$	0.3			Service cost	$	—	$	—	$	0.4	$	0.3	$	—	$	—
Interest cost	Interest cost	0.7		0.9		0		0				Interest cost	0.8		0.7		0.1		—		0.5		—
Expected return on plan assets	Expected return on plan assets	(1.0)		(1.2)		0		0				Expected return on plan assets	(1.0)		(1.0)		—		—		(0.6)		—
Amortizations and other	Amortizations and other	0.9		0.8		0.3		0.3				Amortizations and other	0.4		0.9		0.1		0.3		—		—
Net periodic benefit cost	Net periodic benefit cost	$	0.6	$	0.5	$	0.6	$	0.6			Net periodic benefit cost	$	0.2	$	0.6	$	0.6	$	0.6	$	(0.1)	$	—

The components of net periodic benefit cost other than the service cost component are included in Other ~~(expense)~~ income, net in the condensed consolidated statements of income. During the fiscal year ending December 31, 2021, the Company expects to recognize approximately $3.6 million of amortization in Accumulated other comprehensive loss related to its U.S. pension and OPEB plans and approximately $1.0 million for its French pension plans.

Note 14. Income Taxes

For interim financial reporting, the Company estimates the annual tax rate based on projected taxable income for the full year and records a quarterly income tax provision in accordance with ASC No. 740-270 "Accounting for Income

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Taxes in Interim Periods."These interim estimates are subject to variation due to several factors, including the ability of the Company to accurately forecast pre-tax and taxable income and loss by jurisdiction, changes in laws or regulations, and expenses or losses for which tax benefits are not recognized.Jurisdictions with a projected loss for the year or an actual year-to-date loss where no tax benefit can be recognized are excluded from the estimated annual effective tax rate.The impact of including these jurisdictions on the quarterly effective tax rate calculations could result in a higher or lower effective tax rate during a quarter, based upon the mix and timing of actual earnings versus annual projections.

~~As a result of~~Prior to the Tax Cuts and Jobs Act of 2017, the Company asserted that substantially all of the undistributed earnings of its foreign subsidiaries were considered indefinitely reinvested and accordingly, no deferred taxes were provided. Due to the Tax Act, the Company has significant previously taxed earnings and profits from its foreign subsidiaries, as a result of transition tax, that it is generally able to ~~repatriate~~be repatriated free of U. S. federal tax. In addition, future earnings of foreign subsidiaries are generally expected to be able to be repatriated free of U.S. federal income tax ~~due to transition tax and global intangible low~~because these earnings were taxed ~~income (“GILTI”) treatment. Further, to~~in the ~~extent that any untaxed earnings and profits are distributed from foreign subsidiaries, such dividends should~~U.S. under the GILTI regime or would be eligible for a 100% dividends received deduction. As a result of the Company’s treasury policy to simplify and expediate the intercompany cash flows to SWM US, as evidenced by the implementation of the Cash Pool, and in light of the Company’s demonstrated goal of driving growth though inorganic/acquisitional means, the Company has decided to no longer assert indefinite reinvestment with respect to earnings generated by foreign subsidiaries prior to January 1, 2018.Therefore, the Company does not intend to assert indefinite reinvestment onof its foreign subsidiaries to the extent of each CFC’s earnings ~~generated after December 31, 2017.~~and profits and to the extent of any foreign partnership’s U.S. tax capital accounts. ~~The~~As a result, the Company ~~provides~~has provided for ~~deferred~~ non-U.S. withholding taxes, U.S. federal tax related to currency movement on previously-taxed earnings and profits, and U.S. state taxes on ~~hypothetical repatriation of earnings generated after December 31, 2017.~~unremitted earnings.

All unrecognized tax positions could impact the Company's effective tax rate if recognized. With respect to penalties and interest incurred from income tax assessments or related to unrecognized tax benefits, the Company’s policy is to classify penalties as provision for income taxes and interest as interest expense in its condensed consolidated statement of income. There were 0no material income tax penalties or interest accrued during the three months ended March 31, ~~2021~~2022 or ~~2020.~~2021.

The Company's effective tax rate was ~~26.4%~~131.3% and ~~19.1%~~26.4% for the three months ended March 31, ~~2021~~2022 and ~~2020,~~2021, respectively. The increase was materially due to ~~unfavorable~~ discrete items partially offset by favorable mix of earnings by ~~jurisdiction and a reduction in US tax credits due to foreign law changes.~~

jurisdiction.

~~SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Note 15. Segment Information

The Company's 2 operating product line segments are also the Company's reportable segments: Advanced Materials & Structures and Engineered Papers. The AMS segment ~~primarily~~designs and produces ~~engineered~~ resin-based rolled goods such as nets, films, tapes and meltblown materials, typically through an extrusion process or other ~~non-wovens for use in high-performance applications in~~non-woven technologies across the filtration, transportation, healthcare, construction, and industrial ~~end-markets. It~~end-markets, and it provides converting and adhesive and other coating services related to some of these products. AMS segment consists of the operations of various acquisitions. The EP segment primarily produces various cigarette papers and Recon for sale to cigarette manufacturers. The EP segment also includes non-tobacco paper for battery separators, printing and writing, ~~drinking straw wrap~~foodservice packaging and furniture laminates.

Information about Net Sales and Operating Profit

The accounting policies of these segments are the same as those described in Note 2. Summary of Significant Accounting Policies in the notes to the consolidated financial statements in the Company's Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021. The Company primarily evaluates segment performance and allocates resources based on operating profit. Expense amounts not associated with segments are referred to as unallocated expenses.

($ in millions) Net Sales
Three Months Ended
March 31, 2021 March 31, 2020
AMS $ 163.0 56.6 % $ 122.9 47.0 %
EP 125.2 43.4 138.6 53.0
Total Consolidated $ 288.2 100.0 % $ 261.5 100.0 %

($ in millions) Operating Profit
Three Months Ended
March 31, 2021 March 31, 2020
AMS $ 21.3 63.6 % $ 13.7 40.2 %
EP 29.9 89.2 33.4 97.9
Unallocated (17.7) (52.8) (13.0) (38.1)
Total Consolidated $ 33.5 100.0 % $ 34.1 100.0 %

~~Note 16. Subsequent Events~~

On January 27, 2021, we issued an announcement pursuant to Rule 2.7 of the United Kingdom City Code on Takeovers and Mergers disclosing the terms of a recommended cash offer to acquire the entire issued and to be issued ordinary shares of Scapa Group plc, a company incorporated in England and Wales (“Scapa”), to be effected through a scheme of arrangement (the “Scheme”) under Part 26 of the United Kingdom Companies Act 2006, as amended (the “Acquisition”). Scapa is a UK-based innovation, design, and manufacturing solutions provider for healthcare and industrial markets and has operations across North America, Europe and Asia.

On April 15, 2021, the Scheme became effective in accordance with its terms following delivery to the Registrar of Companies in England and Wales of the orders of the High Court of Justice of England and Wales sanctioning the Scheme, and the Acquisition was completed. The offer price for the Acquisition was £2.15 (approximately $2.96 based on an exchange rate of $1:£1.3788 on April 15, 2021) in cash for each ordinary share of Scapa, valuing the entire ordinary share capital of Scapa at approximately £412.6 million on a fully-diluted basis (approximately $568.9 million). The Company settled the offer consideration with payment to Scapa shareholders under the Scheme on April 29, 2021.

~~As a result of the Acquisition, Scapa will become wholly-owned subsidiaries of the Company and part of the AMS segment.~~

2524

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


($ in millions)	Net Sales


	Three Months Ended
	March 31, 2022				March 31, 2021
AMS	$	272.9	67.1	%	$	163.0	56.6	%
EP	133.9		32.9		125.2		43.4
Total Consolidated	$	406.8	100.0	%	$	288.2	100.0	%

The Company used the proceeds from the $350.0 million Term Loan B Facility, together with up to $325.0 million of the Company’s $500.0 million Revolving Credit Facility, to finance the cash consideration payable to Scapa shareholders under the Scheme and expenses payable in connection with the Acquisition.

~~On April 20, 2021 we settled currency forward contracts with notional amounts of £439 million and £9.6 million, reversing the unrealized loss recognized as of March 31, 2021.~~


($ in millions)	Operating Profit


	Three Months Ended
	March 31, 2022				March 31, 2021
AMS	$	10.3	97.2	%	$	21.3	63.6	%
EP	25.7		N.M.		29.9		89.2
Unallocated	(25.4)		N.M.		(17.7)		(52.8)
Total Consolidated	$	10.6	100.0	%	$	33.5	100.0	%

2625

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following is a discussion of our financial condition and results of operations. This discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this report and the audited consolidated financial statements and related notes and the selected financial data included in our Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021. The discussion of our financial condition and results of operations includes various forward-looking statements about our markets, the demand for our products, our future prospects and other matters. These statements are based on certain assumptions and estimates that we consider reasonable. For information about risks and exposures relating to us and our business, you should read the section entitled "Risk Factors" in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, ~~2020 and~~2021 , the ~~sections~~section entitled "Forward-Looking Statements" at the end of this Item 2.2 and the section entitled “Risk Factors” at Part II – Item 1A hereof. Unless the context indicates otherwise, references to "SWM," "we," "us," "our," the "Company" or similar terms include Schweitzer-Mauduit International, Inc. and our consolidated subsidiaries.

This Management's Discussion and Analysis of Financial Condition and Results of Operations is designed to provide a reader of our financial statements with an understanding of our recent performance, our financial condition and our prospects.

COVID-19 Pandemic

We continue to monitor the impact of the COVID-19 pandemic (including its variant strains) on all aspects of our business. In general, many areas that were resilient to the economic challenges and volatility in 2020 remain healthy, such as tobacco, healthcare, and filtration, while those areas that were most affected, such as transportation and construction, began improving during the fourth quarter of 2020 and continued to perform well during the first quarter of 2021. At present, all of our facilities ~~are~~remain operational. Furthermore, there have been only isolated and temporary customer shutdowns, and the Company is maintaining active dialogue with all key customers and suppliers regarding supply chain and production planning. Many of the Company’s products in our AMS segment have been deemed “essential” (e.g., filtration and healthcare) by local governments and thus the production facilities are not expected to have further shutdowns unless local governments mandate temporary closure or there are additional health and safety concerns beyond the current circumstances.

Given the recent financial results, the Company’s operating cash flows and available liquidity are ample to support operations and financial obligations. The Company also continues to actively assess the credit worthiness of its customers in the context of the potential business disruptions from COVID-19 but has not yet seen evidence of a material change to its ability to collect accounts receivable balances.

~~This is an uncertain period with events and circumstances changing frequently, and while~~Further, senior management is meeting regularly to address all aspects of the pandemic, including employee safety, continuity of business operations, sales and profit impacts directly or indirectly related to the ~~magnitude~~pandemic, and ~~duration of economic disruption is difficult~~potential governmental and third-party responses to ~~predict and will depend on the scope, severity and duration of~~ the pandemic. Further details about the risks and impacts discussed in the section below can be found in the forward-looking statements.

~~End-markets~~In general, our business was resilient in the face of sales volatility and ~~sales.~~ ~~Management believes many~~limited visibility during the early stages of the ~~Company’s end-markets have been and will remain relatively insulated from COVID-19-related economic challenges; however, some end-markets~~pandemic in 2020, while those areas that were ~~temporarily~~most negatively affected, ~~by decreased demand, particularly~~such as transportation ~~which has rebounded since~~and construction, began improving during the peak impacts in mid-2020. In addition, sales results may continue to demonstrate, some variability as customers manage inventories and safety stocks to protect against future potential supply chain disruptions.

~~Tobacco (EP) –~~ The Company’s largest single end-market is the tobacco industry, which has not been materially affected by the pandemic. The Company believes some customers have increased their inventory levels to minimize supply chain impacts of potential future COVID-19 related disruptions.

~~Healthcare (AMS) –~~ ~~Management believes sales of these products, mostly consumables, are not sensitive to COVID-19-related economic weakness.~~

~~Filtration (AMS)~~– The Company believes these products are generally less sensitive to economic volatility than typical industrial goods. Within the portfolio, air filtration products have seen accelerated demand due to heightened focus on air quality and attempts to minimize the spread of COVID-19.

~~Transportation (AMS)~~– ~~The Company’s primary products are aftermarket automotive paint protection films, which faced pronounced temporary near-term negative impacts, beginning late in the first~~fourth quarter of 2020 ~~through most~~and performed well during 2021. Full year 2021 double-digit sales growth in AMS, excluding the benefit of acquisitions, demonstrates the strength of the ~~third quarter of 2020, as a result of significant auto industry disruption and consumer purchasing behaviors as a result of COVID-19.~~demand recovery. However, ~~since late in the third quarter of 2020, the Company’s transportation sales have improved significantly.~~

~~Construction (AMS)~~– Management believes these end-markets have been impacted by local self-distancing regulations that may affect the construction industry, but these end markets have exhibited recent improvements and could be further positively supported by a potential increase in government-sponsored infrastructure spending.

~~Industrial (AMS & EP)~~– ~~The Company’s products service a broad range of applications, some of which are considered to be sensitive to~~increased global economic activity and ~~associated impacts of COVID-19, while other applications~~high demand across many industries has caused significant input cost inflation and strained supply chains, which have ~~been relatively unaffected.~~negatively impacted profitability (more detailed discussion below throughout MD&A).

Liquidity & Debt Overview. The Company currently has ~~$617.9~~$1,276.4 million of total debt, ~~$63.7~~$56.1 million of cash, and undrawn capacity on its $500.0 million revolving line of credit facility (the "Revolving Credit Facility") of ~~$420.2~~$94.7 million at the end of the first quarter of ~~2021.~~2022. Per the terms of the Company's $700.0 million credit agreement (the "Credit Agreement"), net leverage was ~~2.37x~~5.3x at the end of the first quarter, versus a current maximum covenant ratio of ~~4.5x, though covenants contain an acquisition-related provision, allowing net leverage to reach 5.0x throughout 2021.~~5.5x. The Company’s nearest debt maturity is the Revolving Credit Facility which is due in 2023. Please refer to liquidity and capital resources section for additional detail.

~~SUMMARY~~

($ in millions, except per share amounts) Three Months Ended
March 31, Percent of Net Sales
2021 2020 2021 2020
Net sales $ 288.2 $ 261.5 100.0 % 100.0 %
Gross profit 80.8 74.3 28.0 28.4
Restructuring & impairment expense 1.7 0.1 0.6 —
Operating profit 33.5 34.1 11.6 13.0
Interest expense 2.9 6.9 1.0 2.6
Net income $ 21.6 $ 22.5 7.5 % 8.6 %
Diluted earnings per share $ 0.68 $ 0.72
Cash provided by operations $ 12.7 $ 5.1
Capital spending $ (7.1) $ (7.4)

2826

SUMMARY


($ in millions, except per share amounts)	Three Months Ended
	March 31,				Percent of Net Sales
	2022		2021		2022		2021
Net sales	$	406.8	$	288.2	100.0	%	100.0	%
Gross profit	92.6		80.8		22.8		28.0
Restructuring & impairment expense	13.2		1.7		3.2		0.6
Operating profit	10.6		33.5		2.6		11.6
Interest expense	14.5		2.9		3.6		1.0


Net income	$	1.6	$	21.6	0.4	%	7.5	%

Diluted earnings per share	$	0.05	$	0.68
Cash provided by operations	$	5.0	$	12.7
Capital spending	$	8.7	$	7.1

RESULTS OF OPERATIONS

Three Months Ended March 31, ~~2021~~2022 Compared with the Three Months Ended March 31, ~~2020~~2021

Net Sales

($ in millions)


		Three Months Ended									Three Months Ended
		March 31, 2021		March 31, 2020		Change		Percent Change			March 31, 2022		March 31, 2021		Change		Percent Change
Advanced Materials & Structures	Advanced Materials & Structures	$	163.0	$	122.9	$	40.1	32.6	%	Advanced Materials & Structures	$	272.9	$	163.0	$	109.9	67.4	%
Engineered Papers	Engineered Papers	125.2		138.6		(13.4)		(9.7)		Engineered Papers	133.9		125.2		8.7		6.9
Total	Total	$	288.2	$	261.5	$	26.7	10.2	%	Total	$	406.8	$	288.2	$	118.6	41.1	%

Net sales were ~~$288.2~~$406.8 million in the three months ended March 31, ~~2021~~2022 compared with ~~$261.5~~$288.2 million in the prior-year period. The increase in net sales consisted of the following ($ in millions):


		Amount		Percent			Amount		Percent

Changes in volume, product mix and selling prices		$	19.1	7.3	%
Incremental net sales from Scapa						Incremental net sales from Scapa	$	105.5	36.6	%
Changes in volume, product mix and selling prices (excluding Scapa)						Changes in volume, product mix and selling prices (excluding Scapa)	17.4		6.0
Changes due to net foreign currency impacts	Changes due to net foreign currency impacts	7.3		2.8		Changes due to net foreign currency impacts	(4.3)		(1.5)
Changes due to royalties		0.3		0.1

Total	Total	$	26.7	10.2	%	Total	$	118.6	41.1	%

AMS segment net sales were ~~$163.0~~$272.9 million for the three months ended March 31, ~~2021~~2022 compared to ~~$122.9~~$163.0 million during the prior-year period. The increase of ~~$40.1~~$109.9 million or ~~32.6% included~~67.4% includes the benefit from the ~~Tekra~~Scapa acquisition ~~(closed March 13, 2020), and reflected rapid growth in transportation and filtration sales. Tekra~~(completed April 15, 2021). Scapa net sales were ~~$23.6 million and $5.5~~$105.5 million for the three months ended March 31, ~~2021~~2022. The increase in organic sales primarily reflected price increases across the product lines, with the strongest sales gains coming from industrial, construction, and ~~2020, respectively. Transportation sales continued~~filtration end-markets in spite of constrained output due to ~~rebound sharply from negative COVID-19 impacts that began~~some raw material and labor shortages in the ~~first~~U.S. Transportation film sales continue to be unfavorably impacted by raw material shortages, thus declined in the quarter ~~of 2020. Sales into filtration end-markets were up also double digits, driven by~~compared to very strong growth in air filtration, while all other filtration sub-segments increased as well. Healthcare increased, driven by continued robust volumes of woundcare, facemask, and packaging materials. Construction sales ~~increased, led by double-digit growth in key infrastructure and construction applications. Industrial sales declined during the quarter.~~a year ago prior to raw material shortages.

EP segment net sales during the three months ended March 31, ~~2021~~2022 of ~~$125.2~~$133.9 million ~~decreased~~increased by ~~$13.4~~$8.7 million, or ~~9.7%~~6.9%, versus net sales of ~~$138.6~~$125.2 million in the prior-year quarter. The ~~decrease~~increase in net sales was primarily the result of ~~a 6% volume decrease,~~higher volumes and unfavorable price/mix of 8%, partially offset by a 4% currency benefit. Decrease in volume reflected the continued strategic de-emphasis of non-tobacco products, as well as the decrease in high-value LIPprice increases. Volumes benefited from gains across key product lines, including tobacco papers ~~as a result~~and continued strong growth of ~~the transitioning of supplies to a large customer from the Spotswood, NJ facility to other sites while the customer worked through legacy inventories. The decline in LIP papers also~~Heat-not-Burn reduced-risk products. Currency movement negatively impacted ~~mix. These negative factors were partially offset~~the EP net sales by ~~growth in Heat-not-Burn and certain other specialty tobacco paper products.~~3%.

Gross Profit

($ in millions)


		Three Months Ended						Percent Change				Percent of Net Sales							Three Months Ended												Percent Change				Percent of Net Sales
		March 31, 2021		March 31, 2020		Change				2021				2020			March 31, 2022				March 31, 2021				Change								2022				2021
Net sales	Net sales	$	288.2	$	261.5	$	26.7			10.2	%			100.0	%			100.0	%	Net sales	$	406.8			$	288.2			$	118.6			41.2	%			100.0	%			100.0	%
Cost of products sold	Cost of products sold	207.4		187.2		20.2		10.8				72.0				71.6		Cost of products sold	314.2				207.4				106.8				51.5				77.2				72.0
Gross profit	Gross profit	$	80.8	$	74.3	$	6.5	8.7	%			28.0	%			28.4	%	Gross profit	$	92.6			$	80.8			$	11.8			14.6	%			22.8	%			28.0	%

Gross profit increased by ~~$6.5~~$11.8 million during the three months ended March 31, ~~2021~~2022 to ~~$80.8~~$92.6 million versus the prior-year period of ~~$74.3~~$80.8 million.

AMS gross profit increased by ~~$9.2~~$16.5 million, primarily due to ~~strong organic sales growth and~~ the incremental benefit of the acquired ~~Tekra~~Scapa business and organic sales growth driven by price increases. The price increases more than offset higher resin costs

during the quarter compared to prior year. These factors were partially offset by ~~higher input costs, primarily~~the decline in sales of ~~polypropylene resin.~~the transportation films business, which is typically a positive contributor to margins, due to raw material shortages.

In the EP segment, gross profit decreased by ~~$2.7~~$4.7 million primarily ~~due to lower sales and unfavorable price/mix impacts,~~resulting from significantly higher energy costs, especially for natural gas, which escalated rapidly since the Russia/Ukraine conflict began, and higher wood pulp costs and freight costs. The increase in input costs was partially offset by ~~manufacturing cost improvements~~pricing actions and ~~$1.9 million of favorable foreign~~the volume increase. Foreign currency ~~exchange.~~movements negatively impacted gross profit by $0.9 million.

Nonmanufacturing Expenses

($ in millions)


		Three Months Ended						Percent Change				Percent of Net Sales							Three Months Ended												Percent Change				Percent of Net Sales
		March 31, 2021		March 31, 2020		Change				2021				2020			March 31, 2022				March 31, 2021				Change								2022				2021
Selling expense	Selling expense	$	9.1	$	9.5	$	(0.4)			(4.2)	%			3.2	%			3.6	%	Selling expense	$	14.3			$	9.1			$	5.2			57.1	%			3.5	%			3.2	%
Research expense	Research expense	3.8		3.2		0.6		18.8				1.3				1.2		Research expense	5.2				3.8				1.4				36.8				1.3				1.3
General expense	General expense	32.7		27.4		5.3		19.3				11.4				10.5		General expense	49.3				32.7				16.6				50.8				12.1				11.4
Nonmanufacturing expenses	Nonmanufacturing expenses	$	45.6	$	40.1	$	5.5	13.7	%			15.8	%			15.3	%	Nonmanufacturing expenses	$	68.8			$	45.6			$	23.2			50.9	%			16.9	%			15.8	%

Nonmanufacturing expenses in the three months ended March 31, ~~2021~~2022 increased by ~~$5.5~~$23.2 million to ~~$45.6~~$68.8 million from ~~$40.1~~$45.6 million in the prior-year ~~period, primarily due to $3.6~~period. The increase reflected the addition of ongoing SG&A costs from the acquired Scapa operations, an incremental $3.5 million of ~~transaction~~merger and integration related costs, ~~associated with the Scapa acquisition~~ and higher ~~deferred compensation expenses~~general and ~~third party consulting~~administrative expenses.

Restructuring and Impairment Expense

($ in millions)


		Three Months Ended							Percent of Net Sales						Three Months Ended									Percent of Net Sales
		March 31, 2021		March 31, 2020		Change		2021			2020		March 31, 2022				March 31, 2021			Change			2022	2021
Advanced Materials & Structures	Advanced Materials & Structures	$	—	$	—	$	—		—	%		—	%	Advanced Materials & Structures	$	12.9		$	—		$	12.9		4.7	%	—	%
Engineered Papers	Engineered Papers	1.7		0.1		1.6			1.4			0.1		Engineered Papers	$	0.3		$	1.7		$	(1.4)		0.2	%	1.4	%
Unallocated expenses	Unallocated expenses	—		—		—			—			—		Unallocated expenses	—			—			—			—		—
Total	Total	$	1.7	$	0.1	$	1.6		0.6	%		—	%	Total	$	13.2		$	1.7		$	11.5		3.2	%	0.6	%

The Company incurred total restructuring and impairment expense of ~~$1.7~~$13.2 million and ~~$0.1~~$1.7 million in the three months ended March 31, 2022 and 2021, ~~and 2020,~~ respectively.

In the 2022 period, restructuring and impairment expense in the AMS segment included $12.9 million of impairment expenses associated with the planned divestiture of a financially immaterial portion of the business serving the construction end-market.

In the 2022 period, restructuring expense in the EP segment included $0.3 million pension-related restructuring expenses associated with the closure of the Winkler facility in Canada, discussed in Note 9. Restructuring of the notes to the unaudited condensed consolidated financial statements.

In the comparable 2021 period, restructuring expense in the EP segment included $1.4 million related to the 2020 decision to shut down the Spotswood, New Jersey facility and included costs associated with closing the facility, maintaining the property and preparing it for sale.

In the 2021 period the EP segment also recognized $0.3 million of restructuring expenses related to severance accruals for employees at other manufacturing facilities.

~~In the comparable 2020 period, restructuring expense primarily related to ongoing cost optimization initiatives to remain competitive within the EP segment.~~

3029

Operating Profit

($ in millions)


		Three Months Ended						Percent Change				Return on Net Sales							Three Months Ended												Percent Change				Return on Net Sales
		March 31, 2021		March 31, 2020		Change				2021				2020			March 31, 2022				March 31, 2021				Change								2022				2021
Advanced Materials & Structures	Advanced Materials & Structures	$	21.3	$	13.7	$	7.6			55.5	%			13.1	%			11.1	%	Advanced Materials & Structures	$	10.3			$	21.3			$	(11.0)			(51.6)	%			3.8	%			13.1	%
Engineered Papers	Engineered Papers	29.9		33.4		(3.5)		(10.5)				23.9				24.1		Engineered Papers	25.7				29.9				(4.2)				(14.0)				19.2				23.9
Unallocated expenses	Unallocated expenses	(17.7)		(13.0)		(4.7)		(36.2)										Unallocated expenses	(25.4)				(17.7)				(7.7)				43.5
Total	Total	$	33.5	$	34.1	$	(0.6)	(1.8)	%			11.6	%			13.0	%	Total	$	10.6			$	33.5			$	(22.9)			(68.4)	%			2.6	%			11.6	%

Operating profit was ~~$33.5~~$10.6 million in the three months ended March 31, ~~2021~~2022 compared with ~~$34.1~~$33.5 million during the prior-year period.

The AMS segment's operating profit in the three months ended March 31, ~~2021~~2022 was ~~$21.3~~$10.3 million compared to ~~$13.7~~$21.3 million in the prior-year ~~period.~~period, a decrease of $11.0 million, or 51.6%. The 2022 period included a $12.9 million of impairment expenses primarily related to the planned divestiture of a portion of the business serving the construction end-market as discussed above, and also higher purchase accounting costs, due to the Scapa acquisition. Higher raw material costs, other inflationary pressures, and supply chain constraints negatively impacted the operating profit during the first quarter of 2022. The increase ~~of $7.6 million, or 55.5%, reflected strong~~in operating expenses was partially offset by organic sales ~~growth~~gains, including price increases, and the incremental benefit of the acquired ~~Tekra business partially~~Scapa business. The impact of inflationary and supply chain pressures were more than offset by ~~higher raw material costs.~~pricing increases implemented since the prior year quarter.

The EP segment's operating profit in the three months ended March 31, ~~2021~~2022 was ~~$29.9~~$25.7 million, a decrease of ~~$3.5~~$4.2 million, or ~~10.5%~~14.0%, from ~~$33.4~~$29.9 million in the prior-year period. The decrease was primarily driven by ~~lower gross profit~~higher energy costs, particularly in Brazil and France, and higher ~~restructuring expenses as discussed above~~raw material costs and ~~an unfavorable $0.5 million of currency movements impact,~~freight costs. These decreases were partially offset by ~~decreased SG&A~~volume growth and price increases, and lower restructuring expenses ~~from cost control initiatives.~~and other costs primarily related to Spotswood plant shutdown.

Unallocated expenses in the three months ended March 31, ~~2021~~2022 were ~~$17.7~~$25.4 million compared to ~~$13.0~~$17.7 million in the prior-year period, an increase of ~~$4.7~~$7.7 million, or ~~36.2%. The increase was~~43.5%, primarily due to ~~$3.6~~an incremental $3.5 million of ~~transaction~~merger and integration related costs, ~~related to~~and an incremental $1.7 million of costs incurred within Scapa for shared services such as finance, HR, and IT, which were reported in the ~~Scapa acquisition~~Company's segment financials as unallocated expenses. The remainder of the increase was driven by other general and ~~higher deferred compensation expenses.~~administrative costs.

Non-Operating Expenses

Interest expense was ~~$2.9~~$14.5 million in the three months ended March 31, ~~2021, a decrease~~2022, an increase from ~~$6.9~~$2.9 million in the prior-year period. ~~The decrease was primarily due to~~Prior year interest expense included a benefit of $4.5 million ~~prior year expense~~ reversal related to the favorable settlement of Brazil tax ~~assessments as discussed in Note 12. Commitments and Contingencies~~assessments. The remainder of the ~~notes~~increase was primarily due to higher average debt balances as a result of the ~~unaudited condensed consolidated financial statements. Interest expense on debt increased $0.5 million.~~Scapa acquisition.

Other ~~expense,~~income, net, was ~~$2.6~~$5.5 million during the three months ended March 31, ~~2021~~2022, compared to an Other ~~income~~expense of ~~$0.6~~$2.6 million in ~~the~~ prior year ~~quarter, due primarily to~~quarter. The 2022 period included $5.0 million sale of carbon dioxide credits in France as well as $0.5 million gain from the sale of assets of the Winkler facility. The 2021 period included $5.6 million mark-to-market loss of forward currency contracts on the British pound associated with the Scapa ~~acquisition to hedge currency risk of the purchase price during the period between the transaction agreement and closing. This~~acquisition. Prior year Other expense ~~was partially offset by other components of the~~also included a $1.6 million favorable Brazil tax assessment settlement.

Income Taxes

A ~~$7.4~~$2.1 million provision for income taxes in the three months ended March 31, ~~2021~~2022 resulted in an effective tax rate of ~~26.4% compares~~131.3% compared with ~~19.1%~~26.4% in the prior-year quarter. The increase was materially due to ~~unfavorable~~ discrete items partially offset by favorable mix of earnings by ~~jurisdiction and a reduction in US tax credits due to foreign law changes.~~jurisdiction.

Income from Equity Affiliates

Income from equity affiliates, which reflects the results of operations of CTM and CTS, was ~~$1.0~~$2.1 million in the three months ended March 31, ~~2021~~2022 compared with income of ~~$0.0~~$1.0 million during the prior-year period ~~and reflects the results of operations of CTM and CTS.~~due to volume growth.

Net Income and Income per Share

Net income in the three months ended March 31, ~~2021~~2022 was $1.6 million, or $0.05 per diluted share, compared with $21.6 million, or $0.68 per diluted share, ~~compared with $22.5 million, or $0.72 per diluted share,~~ during the prior-year period.

LIQUIDITY AND CAPITAL RESOURCES

A major factor in our liquidity and capital resource planning is our generation of cash flow from operations, which is sensitive to changes in the mix of products sold, ~~sales~~ volume and ~~selling prices~~pricing of our products, as well as changes in our production volumes, costs ~~foreign currency exchange rates~~ and working capital. Our liquidity is supplemented by funds available under our ~~Credit Agreement~~revolving credit facility with a syndicate of banks that is used as either operating conditions or strategic opportunities warrant.

Cash Requirements

As of March 31, ~~2021, $44.1~~2022, $39.3 million of the Company's ~~$63.7~~$56.1 million of cash and cash equivalents was held by foreign subsidiaries. We believe that our sources of liquidity and capital, including cash on-hand, cash generated from operations and our existing credit facilities, will be sufficient to finance our continued ~~operations. We believe the proceeds from our Term Loan B Facility (as defined below) along with our existing credit facilities will be sufficient to fund~~operations, our current and long-term growth ~~plan.~~plan, and dividend payments.

Cash Provided by Operations

Net cash provided by operations was ~~$12.7~~$5.0 million in the three months ended March 31, ~~2021~~2022 compared with ~~$5.1~~$12.7 million in the prior-year period. The ~~increase~~decrease was primarily related to ~~favorable~~unfavorable year-over-year movements in working capital related cash ~~flows.~~flows associated with the sales increases and the related growth in receivables and inventories (higher cost inventories due to rising input costs). Higher cash costs related to advisory and transaction fees associated with the proposed merger with Neenah were partially offset by $23.6 million cash received from the settlement of interest rate swaps.

Working Capital

As of March 31, ~~2021,~~2022, the Company had net working capital of ~~$273.1~~$397.5 million, including cash and cash equivalents of ~~$63.7~~$56.1 million, compared with net working capital of ~~$232.3~~$366.7 million, including cash and cash equivalents of ~~$54.7~~$74.7 million as of December 31, ~~2020.~~2021. These changes primarily reflect the timing of payments and ~~collections.~~collections as well as increased raw material prices and timing of shipments.

In the three months ended March 31, ~~2021,~~2022, net changes in operating working capital used cash of ~~$30.5~~$45.4 million, ~~down~~up from ~~$33.7~~$30.5 million in the prior year period. The increased outflows reflect higher receivables related to timing of collection and sales growth in both EP and AMS, and higher costs of inventories on hand related to significantly higher input costs.

Cash Used for Investing

Cash used for investing activities during the three months ended March 31, ~~2021~~2022 was ~~$7.3~~$9.6 million, compared to ~~$176.3~~$7.3 million in the ~~prior-year. The change primarily reflects the net $170.6 million consideration~~prior year, and was all attributable to ~~acquire Tekra in prior year. Capital~~capital spending and capitalized ~~software totaled $7.6 million, down $0.5 million.~~software.

Cash Provided by Financing Activities

During the three months ended March 31, ~~2021,~~2022, financing activities consisted of ~~$25.0~~$20.0 million proceeds from borrowings under the revolving credit facility, $13.9 million in cash paid for dividends declared to SWM stockholders, $14.4 million payments on long-term debt, $2.2 million payment for debt issuance costs associated with the amendment of our Credit Agreement and the Bridge Facility, as discussed in Note 10 Debt of the notes to the unaudited condensed consolidated financial statements, share repurchases of $2.9 million, and $0.2 million payments on financing leases.

In the prior-year period, financing activities consisted of $25.0 million net proceeds from borrowings under the Revolving Credit Facility, $13.8 million in cash paid for dividends declared to SWM stockholders, share repurchases of $3.1 million, $3.0 million payment for debt issuance costs associated with the amendment of our Credit Agreement, ~~as discussed in Note 10. Debt and Note16. Subsequent Events, of the notes to the unaudited condensed consolidated financial statements,~~ and $0.6 ~~million payments on long-term debt.~~

In the prior-year period, financing activities consisted of $212.0 million net proceeds from borrowings under the Revolving Credit Facility primarily to fund the Tekra acquisition, $13.7 million in cash paid for dividends declared to SWM stockholders, share repurchases of $1.0 million, and $0.4 million payments on long-term debt.

The Company presently believes that the sources of liquidity discussed above are sufficient to meet its anticipated funding needs for the foreseeable future.

Dividend Payments

We have declared and paid cash dividends on our common stock every fiscal quarter since the second quarter of 1996. On May ~~5, 2021,~~4, 2022, we announced a cash dividend of $0.44 per share payable on June ~~18, 2021~~24, 2022 to stockholders of record as of May ~~21, 2021.~~20, 2022. The covenants contained in our Indenture and Credit Agreement require that we maintain certain financial ratios as disclosed in Note 10. Debt of the notes to the unaudited condensed consolidated financial statements, none of which under normal business conditions we would expect to materially limit our ability to pay such dividends. We plan to continue to assess our dividend policy in light of our capital allocation strategy, cash generation, debt levels and ongoing requirements for cash to fund operations and to pursue possible strategic opportunities.

Debt Instruments and Related Covenants


Debt Instruments ($ in millions)	Debt Instruments ($ in millions)	Three Months Ended				Debt Instruments ($ in millions)	Three Months Ended
		March 31, 2021		March 31, 2020				Debt Instruments ($ in millions)	March 31, 2022				March 31, 2021

Proceeds from issuances of long-term debt	Proceeds from issuances of long-term debt	$	25.0	$	212.0				Proceeds from issuances of long-term debt		$	20.0			$	25.0
Payments on long-term debt	Payments on long-term debt	(0.6)		(0.4)				Payments on long-term debt	(14.4)				(0.6)
Net proceeds from borrowings	Net proceeds from borrowings	$	24.4	$	211.6			Net proceeds from borrowings	$	5.6			$	24.4

Net proceeds from borrowings were ~~$24.4~~$5.6 million during the three months ended March 31, ~~2021.~~2022.

On February 10, 2021 we amended our Credit Agreement to, among other things, add a new seven year Term Loan B facility, which provides for additional capacity of $350 million (the "Term Loan B Facility"). The Credit Agreement was further amended effective February 22, 2022 to adjust the step-down schedule for the maximum net debt to EBITDA ratio. See Note ~~10.~~10 Debt ~~and Note 16. Subsequent Events,~~ of the notes to unaudited condensed consolidated financial statements for additional information about the Term Loan B Facility. ~~Other than potential borrowings under the Term Loan B Facility, the Company does not expect to incur any significant additional borrowings during 2021.~~

Unused borrowing capacity under the Credit Agreement was ~~$420.2~~$94.7 million as of March 31, ~~2021.~~2022. We also had availability under our bank overdraft facilities of ~~$6.2~~$1.8 million as of March 31, ~~2021.~~2022.

As discussed in Note 10 Debt, SWM has obtained financing commitments for a $648.0 million senior 364-day unsecured bridge facility and $500.0 million senior secured revolving credit facility in conjunction with the proposed merger with Neenah.

The Company was in compliance with all of its covenants under the Indenture and Credit Agreement at March 31, ~~2021.~~2022. With the current level of borrowing and forecasted results, we expect to remain in compliance with financial covenants under the Credit Agreement.

Our total debt to capital ratios, as calculated under the Credit Agreement, at March 31, ~~2021~~2022 and December 31, ~~2020~~2021 were ~~48.6%~~64.5% and ~~47.7%~~65.1%, respectively.

Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make judgments, assumptions and estimates that affect the amounts reported. There have been no material changes in our critical accounting policies since December 31, 2021.

For further information about our critical accounting policies, please see the discussion of critical accounting policies in our Annual Report on Form 10-K for the year ended December 31, 2021 in the section captioned "Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates.”

Off-Balance Sheet Arrangements

As of March 31, ~~2021,~~2022, we did not have any significant off-balance sheet arrangements, as defined in ~~Item~~

~~303(a)~~Item303(a)(4)(ii) of SEC Regulation S-K.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to the safe harbor created by that Act and other legal protections. Forward-looking statements include, without limitation, those regarding the incurrence of additional debt and expected maturities of the Company’s debt obligations, the adequacy of our sources of liquidity and capital, acquisition integration and growth prospects (including international growth), the cost and timing of our restructuring actions, the impact of ongoing litigation matters and environmental claims, the amount of capital spending and/or common stock repurchases, future cash flows, purchase accounting impacts, impacts and timing of our ongoing operational excellence and other cost-reduction and cost-optimization initiatives, the impact of the COVID-19 pandemic on our operations, profitability, and cash flow, the expected benefits and accretion of the Scapa acquisition and integration and other statements generally identified by words such as "believe," "expect," "intend," "guidance," "plan," "forecast," "potential," "anticipate," "confident," "project," "appear," "future," "should," "likely," "could," "may," "will," "typically" and similar words. These forward-looking statements are prospective in nature and not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the Company’s business shall operate in the future and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These statements are not guarantees of future performance and involve certain risks and

uncertainties that may cause actual results to differ materially from our expectations as of the date of this report. These risks include, among other things, those set forth in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, ~~2020,~~2021, the Risk Factors set forth in the section entitled "Risk Factors" at Part II - Item 1A hereof, as well as the following factors:

•Risks associated with pandemics and other public health emergencies, including the continued ~~spread and~~ impact of, and the governmental and third party response to, the COVID-19 ~~pandemic;~~

•~~The impact~~pandemic and its variant strains (including any proposed new regulation concerning mandatory COVID-19 vaccination of mandatory business closures, limits on non-essential travel, “social or physical distancing” guidelines, “shelter-in-place” mandates and similar governmental and private measures taken to combat the spread of COVID-19;employees);

•Changes in sales or production volumes, pricing and/or manufacturing costs of ~~Recon~~reconstituted tobacco products, cigarette paper (including for LIP cigarettes), including any change by our customers in their tobacco and tobacco-related blends for their cigarettes, their target inventory levels and/or the overall demand for their products, new technologies such as e-cigarettes, inventory adjustments and rebalancings in our EP segment. Additionally, competition and changes in AMS end-market products due to changing customer demands;

•Changes in the Chinese economy, including relating to the demand for reconstituted tobacco, premium cigarettes and netting and due to impact of tariffs;

•Risks associated with the implementation of our strategic growth initiatives, including diversification, and the Company's understanding of, and entry into, new industries and technologies;

•Changes in the source and intensity of competition in our commercial segments. We operate in highly competitive markets in which alternative supplies and technologies may attract our customers away from our products. In addition, our customers may, in some cases, produce for themselves the components that the Company sells to them for incorporation into their products, thus reducing or eliminating their purchases from us;segments;

•Our ability to attract and retain key personnel, ~~due to our prior restructuring actions,~~including in connection with the ~~tobacco industry in which we operate~~merger, labor shortages, labor strikes, stoppages or ~~otherwise;~~other disruptions;

•Weather conditions, including potential impacts, if any, from climate change, known and unknown, seasonality factors that affect the demand for virgin tobacco leaf and natural disasters or unusual weather events;

•Seasonal or cyclical market and industry fluctuations which may result in reduced net sales and operating profits during certain periods;

•Increases in commodity prices and lack of availability of such commodities, including energy, wood pulp and resins, which could impact the sales and profitability of our products;

•Adverse changes in the oil, gas, automotive, construction and infrastructure, and mining sectors impacting key AMS segment customers;

•Increases in operating costs due to inflation or otherwise, such as labor expense, compensation and benefits costs;

•~~Employee retention and labor shortages;~~

•Changes in employment, wage and hour laws and regulations in the U.S., France and elsewhere, including the loi de Securisation de l'emploi in France, unionization rule and regulations by the National Labor Relations Board in the U.S., equal pay initiatives, additional anti-discrimination rules or tests and different interpretations of exemptions from overtime laws;

•~~Labor strikes, stoppages, disruptions or other disruptions at our facilities;~~

•The impact of tariffs, and the imposition of any future additional tariffs and other trade barriers, and the effects of retaliatory trade measures;

•Existing and future governmental regulation and the enforcement thereof, for example relating to the tobacco industry, taxation and the environment (including the impact thereof on our Chinese joint ventures);

•New reports as to the effect of smoking on human health or the environment;

•Changes in general economic, financial and credit conditions in the U.S., Europe, China and elsewhere, including the impact thereof on currency exchange rates (including any weakening of the Euro and Real) and on interest ~~rates and the effects of the ongoing discussions between the U.K. and European Union to determine the terms of the U.K.'s withdrawal from the European Union;~~rates;

•~~Changes in the method pursuant to which LIBOR rates are determined and the~~The phasing out of USD LIBOR rates after ~~2023;~~2023 and the replacement with SOFR;

•Changes in the manner in which we finance our debt and future capital needs, including potential acquisitions;

•The success of, and costs associated with, our current or future restructuring initiatives, including the granting of any needed governmental approvals and the occurrence of work stoppages or other labor disruptions;

•Changes in the discount rates, revenue growth, cash flow growth rates or other assumptions used by the Company in its assessment for impairment of assets and adverse economic conditions or other factors that would result in significant impairment charges;

•~~The~~Supply chain disruptions, including the failure of one or more material suppliers, including energy, resin and pulp suppliers, to supply materials as needed to maintain our product plans and cost structure;

•International conflicts and disputes, which restrict our ability to supply products into affected regions, due to the corresponding effects on demand, the application of international sanctions, or practical consequences on transportation, banking transactions, and other commercial activities in troubled regions;

•Compliance with the FCPA and other anti-corruption laws or trade control laws, as well as other laws governing our operations;

•The pace and extent of further international adoption of LIP cigarette standards and the nature of standards so adopted;

•Risks associated with our 50%-owned, non-U.S. joint ventures relating to control and decision-making, compliance, accounting standards, transparency and customer relations, among others;

•A failure in our risk management and/or currency or interest rate swaps and hedging programs, including the failures of any insurance company or counterparty;

•The number, type, outcomes (by judgment or settlement) and costs of legal, tax, regulatory or administrative proceedings, litigation and/or amnesty programs, including those in Brazil, France and Germany;

•The outcome and cost of the LIP-related intellectual property ~~infringement and validity~~ litigation against Glatz in ~~Europe and the Glatz's German Patent Court invalidation proceedings;~~Europe;

•Risks associated with our technological advantages in our intellectual property and the likelihood that our current technological advantages are unable to continue indefinitely;

•Risks associated with acquisitions, ~~or other~~dispositions, strategic transactions ~~including acquired liabilities~~ and restrictions, retaining customers from businesses acquired, achieving any expected results or synergies from acquired businesses, complying with new regulatory frameworks, difficulties in integrating acquired businesses or implementing strategic transactions generally and risks associated with international acquisition transactions, including in countries where we do not currently have a material presence;

•Risks associated with dispositions, including post-closing claims being made against us, disruption to our other businesses during a sale process or thereafter, credit risks associated with any buyer of such disposed assets and our ability to collect funds due from any such buyer;

•~~Risks associated with our~~ global asset realignment initiatives including: changes in tax law, treaties, interpretations, or regulatory determinations; audits made by applicable regulatory authorities and/or our auditor; and our ability to operate our business in a manner consistent with the regulatory requirements for such realignment;

•~~Increased taxation on tobacco-related products;~~of SWM;

•Costs and timing of implementation of any upgrades or changes to our information technology systems;

•Failure by us to comply with any privacy or data security laws or to protect against theft of customer, employee and corporate sensitive information;

•Changes in tax rates, the adoption of new U.S. or international tax legislation or exposure to additional tax liabilities;

•Changes in construction and infrastructure spending and its impact on demand for certain products;

•Potential loss of consumer awareness and demand for acquired companies’ products if it is decided to rebrand those products under the Company’s legacy brand names;

•The occurrence of any event, change or other circumstances that could give rise to the right of one or both of SWM and Neenah to terminate the merger agreement; the outcome of any legal proceedings that may be instituted against SWM, Neenah or their respective directors;

•The ability to obtain regulatory approvals and meet other closing conditions to the merger on a timely basis or at all, including the risk that regulatory approvals required for the merger are not obtained on a timely basis or at all, or are obtained subject to conditions that are not anticipated or that could adversely affect the combined company or the expected benefits of the transaction;

•The ability to obtain approval by SWM shareholders and Neenah shareholders on the expected terms and schedule;

•Difficulties and delays in integrating SWM and Neenah businesses;

•Failing to fully realize anticipated cost savings and other anticipated benefits of the merger when expected or at all;

•Business disruptions from the proposed merger that will harm SWM’s or Neenah’s business, including current plans and operations;

•Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the merger, including as it relates to SWM’s or Neenah’s ability to successfully renew existing client contracts on favorable terms or at all and obtain new clients;

•The substantial indebtedness SWM expects to incur and assume in connection with the proposed transaction and the need to generate sufficient cash flows to service and repay such debt;

•The possibility that SWM may be unable to achieve expected synergies and operating efficiencies within the expected time-frames or at all and to successfully integrate Neenah’s operations with those of SWM;

•Uncertainty as to the long-term value of the common stock of SWM following the merger, including the dilution caused by SWM’s issuance of additional shares of its common stock in connection with the transaction; and

•Other factors described elsewhere in this document and from time to time in documents that we file with the SEC.

All forward-looking statements made in this document are qualified by these cautionary statements. Forward-looking statements herein are made only as of the date of this document, and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect

changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.

Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such and should only be viewed as historical data.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Our market risk exposure at March 31, ~~2021~~2022 is consistent with, and not materially different than, the market risk and discussion of exposure presented under the caption “Quantitative and Qualitative Disclosures about Market Risk” in Part II, Item 7A of our Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We currently have in place systems relating to disclosure controls and procedures designed to ensure the timely recording, processing, summarizing and reporting of information required to be disclosed in periodic reports under the Securities Exchange Act of 1934, as amended. These disclosure controls and procedures include those designed to ensure that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions about required disclosure. Upon completing our review and evaluation of the effectiveness of our disclosure controls and procedures as of March 31, ~~2021,~~2022, our Chief Executive Officer and Chief Financial Officer have concluded that these controls and procedures were effective as of March 31, ~~2021.~~2022.

Changes in Internal Control Over Financial Reporting

No changes in our internal control over financial reporting were identified as having occurred in the fiscal quarter ended March 31, ~~2021~~2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. During the second quarter of 2021, the Company completed the acquisition of Scapa. As permitted by SEC staff interpretive guidance that an assessment of a recently acquired business may be omitted from the scope of evaluation for a period of up to one year following the acquisition, management excluded Scapa from its interim evaluation of internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

The Company is involved in various legal proceedings and disputes. See Note 20. Commitments and Contingencies of the notes to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, ~~2020~~2021 and Note 12. Commitments and Contingencies of the notes to the unaudited condensed consolidated financial statements included in this report. Except as may have been referenced elsewhere in this report, there have been no material developments with regard to these matters.

Item 1A. Risk Factors

AsOn March 28, 2022, we entered into the merger agreement with Neenah, pursuant to which Neenah will merge with and into a wholly-owned subsidiary of ~~March 31, 2021, there were no material changes in~~SWM, subject to the terms and conditions set forth therein, with Neenah surviving the merger as a wholly-owned subsidiary of SWM. There are a number of risks and uncertainties relating to the proposed merger. Because of these risks, we have supplemented the risk factors previously disclosed in ~~Part I, Item 1A of~~ our Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021, to add the following risk factors:

The market price of SWM common stock after the merger may be affected by factors different from factors that have historically affected and are currently affecting SWM common stock or Neenah common stock.

Upon completion of the merger and the transactions contemplated by the merger agreement, Neenah stockholders will become SWM stockholders, and the combined company will operate an expanded business with a different mix of products, operations and associated risks and liabilities. Accordingly, the results of operations of the combined company and the market price of SWM common stock after the completion of the merger may be affected by factors different from those that have historically affected and are currently affecting the independent results of operations of each of SWM and Neenah and the respective market prices of SWM common stock and Neenah common stock.

Additionally, SWM stockholders and Neenah stockholders may not wish to continue to invest in the combined company, or may wish to dispose of some or all of their SWM common stock. If, before or after the effective time, large amounts of SWM common stock are sold, the market price of SWM common stock could decline.

The dilution caused by the issuance of shares of SWM common stock in connection with the merger may adversely affect the market price of SWM common stock.

The dilution caused by the issuance of SWM common stock as consideration in the merger may result in fluctuations in the market price of SWM common stock, including a stock price decrease.

Holders of SWM common stock will have a diluted ownership percentage and voting interest in the combined company after the merger and will exercise less influence over management.

Holders of SWM common stock currently have the right to vote in the election of the board of directors and on other matters affecting SWM. In the merger, each holder of Neenah common stock who receives shares of SWM common stock will become a holder of common stock of the combined company, with a percentage ownership of the combined company that is smaller than the stockholder’s percentage ownership of, and voting interests in, Neenah immediately prior to the merger. We estimate that, upon completion of the merger, Neenah stockholders as of immediately prior to the merger will collectively own approximately 42% of the outstanding shares of the combined company immediately after the merger, and SWM stockholders as of immediately prior to the merger will collectively own approximately 58% of the outstanding shares of the combined company immediately after the merger (in each case, on a fully diluted basis and without regard to the fact that immediately prior to the merger, certain stockholders may own both SWM common stock and Neenah common stock). In addition, the board of directors of the combined company will be composed of nine (9) directors, of which five (5) will be designated by SWM and four (4) will be designated by Neenah.

Accordingly, SWM stockholders may have less influence on the management and policies of the combined company than they now have on the management and policies of SWM.

Certain of SWM’s and Neenah’s directors and executive officers may have interests in the merger that may differ from the interests of SWM stockholders.

SWM stockholders should be aware that some of the SWM and Neenah directors and executive officers may have interests in the merger and have arrangements that are different from, or in addition to, those of SWM stockholders generally. These interests and arrangements may create potential conflicts of interest, and will be described in the joint proxy statement / prospectus that SWM will deliver to its stockholders in connection with the merger. The SWM board of directors was aware of these interests and considered these interests, among other matters, when making its decision to approve the merger agreement, and in recommending that stockholders vote to approve the merger.

SWM is expected to incur substantial costs related to the merger and the integration of the businesses.

SWM has incurred and expect to incur a number of non-recurring costs associated with the merger. These costs include financial advisory, legal, accounting, consulting and other advisory fees, severance/employee benefit-related costs, financing-related fees and costs, public company filing fees and other regulatory fees, printing costs and other related costs. Many of these costs are payable by SWM regardless of whether or not the merger is completed.

The combined company will also incur substantial integration costs in connection with the merger. There are a large number of processes, policies, procedures, operations, technologies and systems that must be integrated in connection with the merger and the integration of the two companies’ businesses, including purchasing, accounting and finance, sales, payroll, pricing and benefits.

While SWM has assumed that certain expenses would be incurred in connection with the merger and the integration of the businesses, there are many factors beyond SWM’s control that could affect the total amount or the timing of the integration expenses. Moreover, many of the costs that will be incurred are, by their nature, difficult to estimate accurately. Although SWM expects that the elimination of duplicative costs and the realization of other economies of scale-related efficiencies related to the integration of the businesses may offset incremental merger-related and integration costs over time, any net benefit may not be achieved in the near term or at all. These integration costs may result in the combined company taking significant charges against earnings following the completion of the merger, and the amount and timing of such charges are uncertain at present.

Combining SWM and Neenah may be more difficult, costly or time consuming than expected, and SWM may fail to realize some or all of the anticipated benefits of the merger.

The success of the merger will depend, in part, on the ability to realize the anticipated cost savings, operational synergies and other perceived benefits from combining the businesses of SWM and Neenah. To realize the cost savings, operational synergies and other perceived benefits from the merger, SWM must successfully integrate and combine the two businesses in a manner that permits those benefits to be realized. If SWM is not able to achieve these objectives, the anticipated benefits of the merger may not be realized fully or at all, or may take longer to realize than expected. For example, the actual cost savings, operational synergies and other perceived benefits of the merger could be less than anticipated or take longer to realize than anticipated for a variety of reasons, including those set forth in these Risk Factors.

SWM and Neenah have operated and, until the completion of the merger, must continue to operate, independently. It is possible that the integration process could result in the loss of key employees, the disruption of each company’s ongoing businesses or inconsistencies in standards, controls, procedures and policies that adversely affect the companies’ ability to maintain relationships with employees, customers, suppliers or other business associates and constituencies or to achieve the anticipated benefits and cost savings of the merger. Integration efforts between the two companies may also divert management attention and resources. These integration matters could have an adverse effect on SWM during this transition period and for an undetermined period after completion of the merger on the combined company.

The merger may result in a loss of customers, distributors, suppliers, vendors, landlords, joint venture partners and other business partners and may result in the termination of existing contracts.

Following the merger, some of the customers, distributors, suppliers, vendors, landlords, joint venture partners and other business partners of SWM or Neenah may terminate or scale back their current or prospective business relationships with the combined company. Some customers may not wish to source a larger percentage of their needs from a single company or may feel that the combined company is too closely allied with one of their competitors. In addition, SWM and Neenah have contracts with customers, distributors, suppliers, vendors, landlords, joint venture partners and other business partners that may require SWM or Neenah to obtain consents from these other parties in connection with the merger, which may not be obtained on favorable terms or at all. If relationships with customers, distributors, suppliers, vendors, landlords, joint venture partners and other business partners are adversely affected by the merger, or if the combined company, following the merger, loses the benefits of the contracts of SWM or Neenah, the combined company’s business and financial performance could suffer.

The combined company may be unable to retain SWM or Neenah personnel successfully prior to the effective time or after the merger is completed.

The success of the merger will depend in part on the combined company’s ability to retain the talents and dedication of key employees currently employed by SWM and Neenah. It is possible that these employees may decide not to remain with SWM or Neenah, as applicable, prior to the effective time or with the combined company after the merger is consummated. If SWM is unable to retain key employees, including management, who are critical to the successful integration and future operations of the companies, SWM could face disruptions in its operations, loss of existing customers, loss of key information, expertise or know-how and unanticipated additional recruitment costs. In addition, if key employees terminate their employment, the combined company’s business activities may be adversely affected, and management’s attention may be diverted from successfully integrating SWM and Neenah to hiring suitable replacements, all of which may cause the combined company’s business to suffer. In addition, SWM may not be able to locate or retain suitable replacements for any key employees who leave the company.

The combined company’s future results may suffer if it does not effectively manage its expanded operations following the merger.

Following the merger, the size of the business of the combined company will increase significantly beyond the current size of either SWM’s or Neenah’s business. The combined company’s future success will depend, in part, upon its ability to manage this expanded business, which will pose substantial challenges for management, including challenges related to the management and monitoring of new operations and associated increased costs and complexity. There can be no assurances that the combined company will be successful or that it will realize the expected operating efficiencies, cost savings, revenue enhancements or other benefits currently anticipated from the merger.

The merger agreement subjects SWM to restrictions on its business activities prior to the effective time.

The merger agreement subjects SWM to restrictions on its business activities prior to the effective time. The merger agreement obligates SWM to, and to cause each of its subsidiaries to, subject to specified exceptions, conduct its business in the ordinary course in all material respects and use reasonable best efforts to maintain and preserve intact its business organization, employees and advantageous business relationships. These restrictions could prevent SWM from pursuing certain business opportunities that arise prior to the effective time and are outside the ordinary course of business.

The merger agreement limits SWM’s ability to pursue alternatives to the merger and may discourage other companies from trying to acquire SWM.

The merger agreement contains “no shop” covenants that restrict SWM’s ability to, directly or indirectly, initiate, solicit, knowingly encourage or knowingly facilitate any inquiries or proposals with respect to any acquisition

proposal, engage or participate in any negotiations with any person concerning any acquisition proposal, provide any confidential or nonpublic information or data to, or have or participate in any discussions with, any person relating to any acquisition proposal, subject to certain exceptions, or, unless the merger agreement has been terminated in accordance with its terms, approve or enter into any term sheet, letter of intent, commitment, memorandum of understanding, agreement in principle, acquisition agreement, merger agreement or other agreement in connection with or relating to any acquisition proposal.

The merger agreement further provides that, during the 12-month period following the termination of the merger agreement under specified circumstances, including the entry into a definitive agreement or consummation of a transaction with respect to an alternative acquisition proposal, SWM may be required to pay Neenah a cash termination fee equal to $24 million.

The merger agreement may be terminated in accordance with its terms and the merger may not be completed, which could negatively affect SWM or Neenah, and, in certain circumstances, result in the requirement that SWM or Neenah pay a termination fee.

If the merger agreement is terminated and the merger is not completed, including as a result of either SWM stockholders failing to approve the SWM issuance proposal or Neenah stockholders failing to approve the Neenah merger proposal, there may be various adverse consequences, and SWM may experience negative reactions from the financial markets and from its customers and employees. For example, SWM’s business may have been affected adversely by the failure to pursue other beneficial opportunities due to the focus of management on the merger, without realizing any of the anticipated benefits of completing the merger. Additionally, SWM has incurred and will incur substantial costs in connection with the negotiation and completion of the transactions contemplated by the merger agreement. If the merger is not completed, SWM would have to recognize these as expenses without realizing the expected benefits of the merger. Moreover, if the merger agreement is terminated, the market price of SWM common stock could decline to the extent that the current market prices reflect a market assumption that the merger will be completed. If the merger agreement is terminated under certain circumstances, SWM may be required to pay a termination fee of $24 million to Neenah.

SWM will incur indebtedness in connection with the merger, which could adversely affect SWM and the combined company, including by decreasing the business flexibility of the combined company.

Consummation of the merger is not conditioned on SWM’s ability to obtain financing. SWM plans to use debt financing and cash on hand to fund certain fees and costs relating to the merger and to refinance certain of its existing indebtedness and certain existing indebtedness of Neenah. Such debt financing could take any of several forms or any combination of them, including but not limited to the following: (i) SWM may borrow up to [$650.0 million] under the delayed draw facility; (ii) SWM may borrow under the revolving credit facility; (iii) SWM may borrow under the bridge facility; and (iv) SWM may issue senior notes in the public and/or private capital markets.

SWM’s increased level of debt and the covenants to which SWM will have agreed in connection with this debt financing could have negative consequences on SWM and the combined company, including, among other things, (i) requiring SWM, and the combined company, to dedicate a larger portion of cash flow from operations to servicing and repayment of the debt, (ii) reducing funds available for strategic initiatives and opportunities, working capital and other general corporate needs and (iii) limiting SWM’s, and the combined company’s, ability to incur certain kinds or amounts of additional indebtedness, which could restrict its flexibility to react to changes in its business, its industry and economic conditions.

Regulatory approvals may not be received, may take longer than expected, and regulatory authorities may impose conditions or requirements that are not presently anticipated or that could have an adverse effect on the combined company following the merger.

Before the merger can be completed, certain approvals, consents, clearances, orders and authorizations must be obtained from various antitrust and regulatory authorities in the United States and in foreign jurisdictions. The governmental entities from which these approvals are required may refuse to approve the merger or impose

conditions or requirements for the completion of the merger. Any conditions or requirements imposed could have the effect of delaying or preventing completion of the merger. Even if the requisite regulatory approvals are granted, the relevant regulatory authorities may impose conditions, limitations, obligations or costs, or place restrictions on the conduct of the combined company’s business or require changes to the terms of the transactions contemplated by the merger agreement.

There can be no assurance that regulators will not impose any such conditions, limitations, obligations or restrictions and that such conditions, limitations, obligations or restrictions will not have the effect of delaying the completion of any of the transactions contemplated by the merger agreement, imposing additional material costs on or materially limiting the revenues of the combined company following the merger or otherwise reduce the anticipated benefits of the merger if the merger were consummated successfully within the expected timeframe.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities By the Issuer and Affiliated Purchasers

The following table indicates the cost of and number of shares of the Company's common stock it repurchased during ~~2021:~~2022:

Issuer Purchases of Equity Securities
Period Total
Number of
Shares
Purchased Average
Price
Paid per
Share Total Number of Shares
Purchased as Part of
Publicly Announced
Programs Approximate Dollar Value of Shares that May Yet be Purchased Under the Programs
(# shares) ($ in millions) ($ in millions)
January 1 - 31, 2021 619 $ 41.84
February 1 - 28, 2021 66,110 45.87 — — —
March 1-31, 2021 — —
Total Year-to-Date 2021 66,729 $ 45.83 — — —


Issuer Purchases of Equity Securities
Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Programs			Approximate Dollar Value of Shares that May Yet be Purchased Under the Programs
				(# shares)	($ in millions)		($ in millions)
January 1 - 31, 2022	976	$	29.90	—	—		—
February 1 - 28, 2022	92,601	30.98		—	—		—
March 1-31, 2022	1,270	29.87
Total Year-to-Date 2022	94,847	$	30.96	—	$	—	—

From time to time, the Company uses corporate 10b5-1 plans to allow for share repurchases to be made at predetermined stock price levels, without restricting such repurchases to specific windows of time. Any future common stock repurchases will be dependent upon various factors, including the Company's stock price, strategic opportunities and cash availability.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

3741

Item 6. Exhibits


Exhibit Number						Exhibit
2.1						~~Rule 2.7 Announcement,~~Agreement and Plan of Merger, dated ~~January 27, 2021 (incorporated~~as of March 28, 2022, by and among SWM, Neenah and Samurai Warrior Merger Sub, Inc. (incoporated by reference to Exhibit 2.1 to the ~~Company’s~~Company's Current Report on Form 8-K filed ~~January 27, 2021).~~on March 28, 2022)
~~2.2~~						~~Announcement for the Revised Offer, dated March 8, 2021 (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed March 8, 2021).~~
~~2.3~~						Co-operation Agreement, dated January 27, 2021, between AMS Holdco 2 Limited and Scapa Group plc. (incorporated by reference to Exhibit 2.2 to the Company’s Current Report on Form 8-K filed January 27, 2021).
3.1						Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 10-Q for the quarter ended September 30, 2009).
3.2						Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on February 22, 2019).
10.1						~~First Amendment, dated as~~Commitment Letter of February 9, 2021, to the Credit Agreement, dated September 25, 2018, by and among Schweitzer-Mauduit International, Inc., SWM Luxembourg, the other loan parties party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., ~~as administrative agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 10, 2021).~~dated March 28, 2022
~~10.2~~						~~Form of Director Deed of Irrevocable Undertaking (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on January 27, 2021).~~
~~10.3~~						Backstop Credit Agreement, dated as of January 27, 2021, among Schweitzer-Mauduit International, Inc., the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, and JPMorgan Chase Bank, N.A., as bookrunner and lead arranger (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on January 27, 2021)
31.1						Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934, as amended.
31.2						Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934, as amended.
32						Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101						The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, ~~2021,~~2022, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the condensed consolidated statements of income, (ii) the condensed consolidated statements of comprehensive income (loss), (iii) the condensed consolidated balance sheets, (iv) the condensed consolidated statements of changes in stockholders' equity, (v) the condensed consolidated statements of cash flow, and (vi) notes to condensed consolidated financial statements.
104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit101).

3842

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Schweitzer-Mauduit International, Inc.

(Registrant)

By:

/s/ Andrew Wamser

Andrew Wamser
Executive Vice President and
Chief Financial Officer
(duly authorized officer and principal financial officer)

May ~~5, 2021~~4, 2022

By:

/s/ Michael Schmit

Michael Schmit
Corporate Controller and
Chief Accounting Officer
(principal accounting officer)

May ~~5, 2021~~4, 2022

3943

GLOSSARY OF TERMS

The following are definitions of certain terms that may be used in this Quarterly Report on Form 10-Q filing:

•"Total debt to capital ratio" is total debt divided by the sum of total debt and total stockholders' equity.

•"Reconstituted tobacco" is produced in two forms: leaf, or reconstituted tobacco leaf, and wrapper and binder products. Reconstituted tobacco leaf is blended with virgin tobacco as a design aid to achieve certain attributes of finished cigarettes. Wrapper and binder are reconstituted tobacco products used by manufacturers of cigars.

•"Reverse osmosis" is a water purification technology that uses a semipermeable membrane to remove larger particles from drinking water.

•"Tobacco paper" includes cigarette paper which wraps the column of tobacco within a cigarette and has varying properties such as basis weight, porosity, opacity, tensile strength, texture and burn rate, as well as plug wrap paper which wraps the outer layer of a cigarette filter and is used to hold the filter materials in a cylindrical form, and tipping paper which joins the filter element to the tobacco-filled column of the cigarette and is both printable and glueable at high speeds.

4044


	March 31, 2021		December 31, 2020


Accumulated pension and OPEB liability adjustments, net of income tax benefit of $12.2 million and $11.6 million at March 31, 2021 and December 31, 2020, respectively	$	(18.8)	$	(20.5)
Accumulated unrealized loss on derivative instruments, net of income tax benefit of $2.8 million and $2.8 million at March 31, 2021 and December 31, 2020, respectively	(8.7)		(13.1)
Accumulated unrealized foreign currency translation adjustments, net of income tax benefit of $6.8 million and $10.1 million at March 31, 2021 and December 31, 2020, respectively	(88.2)		(78.3)
Accumulated other comprehensive loss	$	(115.7)	$	(111.9)


	Fair Value as of March 13, 2020		Weighted-Average Amortization Period (Years)
Amortizable intangible assets:
Customer relationships	$	63.0	15
Tradenames and other	10.8		15
Developed technology	8.0		10
Total amortizable intangible assets	$	81.8


	AMS		EP		Total
Goodwill as of December 31, 2020	$	398.4	$	5.3	$	403.7

Foreign currency translation adjustments	(1.7)		(0.2)		(1.9)
Goodwill as of March 31, 2021	$	396.7	$	5.1	$	401.8


Derivatives Designated in Hedging Relationships	Unrealized (Loss) Gain Recognized in AOCI on Derivatives, Net of Tax				Location of (Loss) Gain Reclassified from AOCI	(Loss) Gain Reclassified from AOCI

	Three Months Ended						Three Months Ended
	March 31,						March 31,
	2021		2020					2021		2020
Derivatives designated as cash flow hedge
Foreign exchange contracts	$	(0.6)	$	(5.0)			Net sales	$	(0.6)	$	(0.6)
Foreign exchange contracts	0.9		0.5				Other income (expense), net	0.7		0.6
Interest rate contracts	4.1		(8.2)				Interest expense	0		0
Derivatives designated as net investment hedge
Foreign exchange contracts	7.0		12.0				Other income (expense), net	0		0
Total	$	11.4	$	(0.7)				$	0.1	$	0